RAB9B: Comprehensive Functional Annotation Report

Introduction

RAB9B (Ras-related protein Rab-9B, also known as Rab-9-like protein or Rab-9L) is a member of the Rab family of small GTPases in humans, encoded by the RAB9B gene located on the X chromosome (Xq22.2). The protein is characterized by UniProt accession Q9NP90 and functions as a molecular switch in membrane trafficking, cycling between an active GTP-bound state and an inactive GDP-bound state [uniprot-q9np90-rab9b]. As a Rab family GTPase with EC number 3.6.5.2, RAB9B catalyzes the hydrolysis of GTP to GDP, a reaction that is central to its regulatory function in vesicular transport.

RAB9B is one of two human Rab9 paralogs, the other being RAB9A, which arose from a gene duplication event that occurred prior to the divergence of jawed vertebrates. While most of the functional characterization in the literature has focused on RAB9A (commonly referred to simply as "Rab9"), the high sequence homology between the two proteins suggests that RAB9B performs similar functions in late endosome-to-trans-Golgi network (TGN) transport [wu-2014-rab9a-rutbc2-structure-abstract]. Indeed, biochemical data demonstrate that Rab9B can bind to the effector RUTBC2 in a manner similar to Rab9A, supporting functional equivalence in at least some pathways [shu-2012-rutbc2-abstract].

The primary function attributed to Rab9 proteins is the recycling of mannose 6-phosphate receptors (MPRs) from late endosomes back to the TGN, a critical step in lysosome biogenesis [stenmark-2001-lysosome-biogenesis-abstract]. This transport pathway ensures that MPRs, which deliver newly synthesized lysosomal hydrolases from the Golgi to endosomes, are efficiently recycled for additional rounds of enzyme delivery. Additionally, Rab9 has been implicated in non-canonical (Atg5/Atg7-independent) autophagy, where it mediates fusion of isolation membranes with vesicles derived from the trans-Golgi and late endosomes [nishida-2009-alternative-autophagy-abstract].

Molecular Function and GTPase Activity

RAB9B functions as a small GTPase, belonging to the Ras superfamily of GTP-binding proteins. The protein contains the canonical structural features of this family, including a P-loop NTPase fold, characteristic switch regions (switch I and switch II), and a C-terminal prenylation motif that enables membrane association. The crystal structure of Rab9 has been determined at 1.25-Å resolution, revealing a nucleotide binding fold consisting of a six-stranded β-sheet surrounded by five α-helices with a tightly bound nucleotide in the active site [chen-2004-rab9-structure-abstract]. The structure for GppNHp-bound RAB9B has been deposited in the Protein Data Bank with identifier 2OCB.

The GTPase cycle of RAB9B is regulated by guanine nucleotide exchange factors (GEFs) that promote GDP-to-GTP exchange, and GTPase-activating proteins (GAPs) that accelerate the intrinsic GTP hydrolysis rate. In its active GTP-bound state, RAB9B adopts a conformation that allows it to recruit specific effector proteins to membrane surfaces. The switch I and switch II regions undergo substantial conformational changes between the GDP- and GTP-bound states, enabling selective recognition by effector proteins [chen-2004-rab9-structure-abstract]. Notably, structure-based sequence alignment reveals that while Rab9 shares conserved active site residues with other Rab proteins (implying a common catalytic mechanism), it contains seven regions with significantly different conformations that may contribute to its specificity for particular effectors [chen-2004-rab9-structure-abstract].

The cycling of Rab proteins between membranes and cytosol is further regulated by GDP dissociation inhibitor (GDI), which extracts the GDP-bound form of the Rab from membranes and maintains it in a soluble cytosolic pool. Upon encountering the appropriate GEF at target membranes, GDI releases the Rab, allowing nucleotide exchange and stable membrane association.

A critical prerequisite for Rab membrane association is C-terminal prenylation. Like most Rab family members, RAB9B is modified by the attachment of geranylgeranyl groups to C-terminal cysteine residues. This reaction is catalyzed by Rab geranylgeranyltransferase (RabGGTase) in conjunction with Rab escort protein (REP). The majority of Rab proteins contain C-terminal motifs ending in CC, CxC, or CCxx, where both cysteines are geranylgeranylated. Dual prenylation is essential for proper membrane targeting; mono-prenylated Rab proteins are mistargeted to the endoplasmic reticulum and are non-functional. The geranylgeranyl groups are masked by GDI when Rabs are cytosolic, and exposed upon membrane insertion. The affinity of prenylated Rab9 for GDI is in the nanomolar range, indicating tight regulation of the cytosolic pool.

Subcellular Localization and Membrane Trafficking

RAB9B, like its paralog RAB9A, localizes primarily to late endosomes, where it occupies a distinct membrane microdomain that is segregated from Rab7-containing regions [barbero-2002-rab9-visualization-abstract]. Videomicroscopy of living cells expressing fluorescently tagged Rab9 revealed that Rab9 and Rab7 domains exhibit only approximately 15% overlap on late endosomal membranes, suggesting compartmentalized functionality within these organelles. This "macaroon cookie" arrangement of distinct Rab domains supports the model that different Rab proteins organize functionally distinct regions of the same organelle [barbero-2002-rab9-visualization-abstract].

The Rab9 microdomain is enriched in mannose 6-phosphate receptors, with approximately 40% of Rab9-positive structures containing detectable CI-MPR compared to only 16% of Rab7-positive structures [barbero-2002-rab9-visualization-abstract]. This selective enrichment is consistent with Rab9's function in organizing cargo for retrograde transport to the TGN. Small Rab9-positive vesicles have been directly observed budding from late endosomes and fusing with TGN structures marked by galactosyltransferase, establishing vesicles rather than tubules as the primary transport carriers in this pathway [barbero-2002-rab9-visualization-abstract].

The transport of Rab9-bearing vesicles is microtubule-dependent, with vesicle velocities of approximately 0.75 μm/s under normal conditions. Treatment with nocodazole (a microtubule-depolymerizing agent) reduced vesicle velocity to approximately 0.2 μm/s, indicating that while microtubules enhance transport efficiency, the pathway remains viable even without intact microtubules [barbero-2002-rab9-visualization-abstract].

According to the Human Protein Atlas, RAB9B shows membranous and cytoplasmic expression in most tissues, with the highest expression observed in intercalated discs of heart myocytes [human-protein-atlas-rab9b]. At the RNA level, heart muscle shows the highest expression (20.1 nTPM), followed by cerebellum (16.7 nTPM), basal ganglia (9.9 nTPM), and seminal vesicle (8.9 nTPM). In the brain, expression is relatively uniform across regions with the highest levels in the hypothalamus (21.7 nTPM). This tissue distribution pattern differs somewhat from RAB9A, which shows more ubiquitous expression with particular enrichment in glandular and lymphoid cells.

Interacting Partners and Effector Proteins

The function of RAB9B in membrane trafficking is mediated through interactions with multiple effector proteins that carry out specific steps in vesicle formation, transport, and fusion. The best-characterized effectors are TIP47, p40, GCC185, and RUTBC2.

TIP47 (Tail-Interacting Protein of 47 kDa): TIP47 is a cytosolic adaptor protein essential for the transport of mannose 6-phosphate receptors from endosomes to the TGN. Rab9 recruits TIP47 from the cytosol to late endosome surfaces, where it binds to the cytoplasmic domains of MPRs with enhanced affinity [hanna-2002-tip47-rab9-abstract]. The affinity of TIP47 for Rab9-GTPγS is remarkably high (Kd = 95 nM), approximately 10-fold stronger than TIP47's intrinsic affinity for MPR cytoplasmic domains [ganley-2004-rab9-endosome-size-abstract]. This cooperative binding mechanism ensures efficient cargo selection during vesicle formation. Strikingly, TIP47 is also essential for Rab9 stability; depletion of TIP47 reduces Rab9 half-life fourfold (from 32 to 8 hours), representing the first evidence that an effector interaction is essential for Rab protein stability [ganley-2004-rab9-endosome-size-abstract].

p40: p40 is a 40-kDa protein that binds Rab9-GTP with approximately fourfold preference over Rab9-GDP [pfeffer-2009-multiple-routes-abstract]. Unlike TIP47, p40 does not interact with Rab7 or K-Ras, indicating selectivity for the Rab9 pathway. Anti-p40 antibodies inhibit MPR transport in vitro, confirming its functional importance. p40 and Rab9 show synergy in stimulating MPR transport, consistent with a model where they act together to drive transport vesicle docking [pfeffer-2009-multiple-routes-abstract].

GCC185: GCC185 is a TGN-localized golgin (coiled-coil tethering protein) that functions as a Rab9 effector required for MPR recycling [reddy-2006-gcc185-abstract]. GCC185 binds Rab9 with strong preference for its active, GTP-bound conformation. Depletion of GCC185 causes approximately 75% inhibition of MPR recycling and results in accumulation of MPRs in peripheral vesicular structures containing Rab9 [reddy-2006-gcc185-abstract]. GCC185 is proposed to participate in docking of late endosome-derived, Rab9-bearing transport vesicles at the TGN. Unlike other golgins, GCC185 binds poorly to Arl1 GTPase and instead uses direct Rab9 interaction for its tethering function.

RUTBC2: RUTBC2 is a TBC domain-containing protein that binds to both Rab9A and Rab9B in their GTP-bound states [shu-2012-rutbc2-abstract]. The crystal structure of the Rab9A-RUTBC2 complex reveals that RUTBC2 uses a pleckstrin homology domain fold to interact with the switch and interswitch regions of Rab9A [wu-2014-rab9a-rutbc2-structure-abstract]. Importantly, while RUTBC2 is a Rab9 effector, it is not a GAP for Rab9 itself; instead, it functions as a GAP for Rab36 and Rab34 [shu-2012-rutbc2-abstract]. This suggests a functional connection between Rab9-mediated receptor recycling pathways and Rab36-regulated lysosomal positioning, representing a potential coordination mechanism in membrane trafficking. RUTBC2 is highly enriched in brain tissue.

Role in Lysosome Biogenesis and Autophagy

The primary physiological function of Rab9 proteins is ensuring efficient lysosome biogenesis through proper sorting of lysosomal enzymes. Mannose 6-phosphate receptors bind newly synthesized lysosomal hydrolases in the Golgi complex and deliver them to endosomes. Following cargo release in the acidic endosomal environment, MPRs must recycle back to the TGN for additional rounds of enzyme delivery [stenmark-2001-lysosome-biogenesis-abstract]. Expression of dominant-negative Rab9 (S21N mutation) strongly inhibits MPR recycling, demonstrating the importance of Rab9 GTPase activity for this pathway.

Depletion of Rab9 from cells has multiple phenotypic consequences: late endosome diameter decreases by approximately 45% (from 0.76 to 0.42 μm), with concomitant reduction in the numbers of multilamellar and dense tubule-containing structures [ganley-2004-rab9-endosome-size-abstract]. The remaining late endosomes and lysosomes become more tightly clustered near the nucleus, implicating Rab9 in endosome positioning through motor protein recruitment. Importantly, multivesicular endosome numbers remain unchanged, and EGF receptor degradation rates are unaffected, indicating that Rab9 depletion specifically affects the retrograde transport pathway without globally disrupting endosome function [ganley-2004-rab9-endosome-size-abstract].

Beyond its role in constitutive MPR recycling, Rab9 has been implicated in non-canonical autophagy. The landmark discovery by Nishida and colleagues demonstrated that cells lacking ATG5 or ATG7 can still form autophagosomes and perform autophagic protein degradation under certain stress conditions through an alternative, Rab9-dependent mechanism [nishida-2009-alternative-autophagy-abstract]. In this Atg5/Atg7-independent pathway, autophagosomes are generated by Rab9-mediated fusion of isolation membranes (phagophores) with vesicles derived from the trans-Golgi and late endosomes. Unlike conventional autophagy, LC3 lipidation does not occur in this alternative pathway. This form of autophagy has physiological importance in specific contexts, including degradation of secretory proteins such as insulin granules and mitochondrial elimination in reticulocytes [nishida-2009-alternative-autophagy-abstract].

Role in Cholesterol Homeostasis and Niemann-Pick Type C Disease

Beyond its well-established role in MPR recycling, Rab9 has been implicated in cholesterol trafficking and homeostasis within the endolysosomal system. This connection is particularly evident in Niemann-Pick type C (NPC) disease, an autosomal recessive neurodegenerative disorder characterized by massive accumulation of cholesterol and glycosphingolipids within late endosomes and lysosomes. Approximately 95% of NPC patients harbor mutations in the NPC1 gene, which encodes a large late endosomal protein with 13 transmembrane domains involved in cholesterol export.

Studies by Ganley and Pfeffer demonstrated that cholesterol accumulation directly affects Rab9 function in NPC1-deficient cells [ganley-2006-npc-cholesterol-abstract]. Endogenous Rab9 levels were elevated 1.8-fold in NPC cells compared to wild-type cells, and its half-life increased from 44 to 70 hours, indicating that Rab9 accumulation results from impaired protein turnover rather than increased synthesis. The underlying mechanism involves cholesterol-mediated stabilization of Rab9 on late endosome membranes. In normal cells, over 90% of Rab9 can be extracted from membranes by GDI, but in NPC cells, only 35% is extractable. This GDI resistance correlates directly with membrane cholesterol concentration, as demonstrated using artificial liposomes [ganley-2006-npc-cholesterol-abstract].

The functional consequence of Rab9 sequestration is disruption of the retrograde transport pathway. In NPC1-depleted cells, cation-dependent mannose 6-phosphate receptors are missorted to lysosomes for degradation, with CD-MPR levels dropping by approximately 70%. This creates a vicious cycle: impaired Rab9 function leads to defective MPR recycling, which compromises lysosomal enzyme delivery and further exacerbates the lysosomal storage phenotype.

Importantly, Rab9 overexpression provides therapeutic benefit in NPC disease models. GFP-tagged Rab9 expression rescued CD-MPR degradation and relieved cholesterol accumulation in NPC cells. Furthermore, protein transduction of Rab9 reduced intracellular cholesterol in NPC2 fibroblasts and cultured mouse NPC1 neurons [ganley-2006-npc-cholesterol-abstract]. These findings suggest that enhancing Rab9-mediated vesicular export could provide a therapeutic bypass for cholesterol removal from late endosomes, representing a potential treatment strategy for NPC disease. The Rab9 pathway also mediates transport of lactosylceramide (LacCer) from the plasma membrane to the Golgi apparatus; overexpression of wild-type Rab9 corrects abnormal LacCer transport in several sphingolipid storage disease cell types, further supporting its therapeutic potential.

Comparison with RAB9A

RAB9B and RAB9A arose from a gene duplication that occurred prior to the divergence of jawed vertebrates, and both proteins share high sequence homology. Phylogenetic analysis shows highly supported sister clades comprising Rab9a and Rab9b sequences from fish, amphibians, birds, and mammals. The functional redundancy of these paralogs is supported by biochemical data showing that RAB9B can bind to effector RUTBC2 in a manner similar to RAB9A [wu-2014-rab9a-rutbc2-structure-abstract].

However, the two paralogs show distinct tissue expression patterns. While RAB9A is ubiquitously expressed with enrichment in glandular and lymphoid cells, RAB9B shows enhanced expression in heart muscle and is also expressed in brain regions including cerebellum and basal ganglia [human-protein-atlas-rab9b]. In the nervous system, RAB9A is abundantly present in oligodendroglial lineage cells, whereas RAB9B does not exhibit a specific profile across brain cell types. This differential expression pattern suggests potential tissue-specific or context-dependent roles, though the functional significance remains to be fully elucidated.

Notably, patients with deletions encompassing the PLP1 gene (causing Pelizaeus-Merzbacher disease, a hypomyelinating leukodystrophy) often have concomitant deletion of RAB9B due to the antiparallel arrangement of these genes on chromosome Xq22. Analysis of a patient with a 73-kb deletion including both PLP1 and RAB9B suggests that "lack of RAB9B may not be deleterious in itself," possibly due to functional compensation by RAB9A [ohira-2012-plp1-rab9b-deletion-abstract].

Disease Associations and Potential Therapeutic Relevance

RAB9B has been identified as one of several Rab proteins that serve as substrates for LRRK2 (Leucine-Rich Repeat Kinase 2), whose mutations comprise the predominant genetic cause of familial Parkinson's disease [steger-2016-lrrk2-rab-phosphoproteomics-abstract]. In vitro kinase assays demonstrated that LRRK2 phosphorylates RAB9B along with other Rab proteins including Rab1A/B, Rab3C, Rab8A/B, Rab10, Rab23, and Rab35. LRRK2 phosphorylates these substrates on an evolutionarily conserved residue in the switch II domain, and pathogenic LRRK2 mutations increase this phosphorylation, strongly decreasing Rab affinity for regulatory proteins including GDIs [steger-2016-lrrk2-rab-phosphoproteomics-abstract]. Dysregulated Rab phosphorylation by hyperactive LRRK2 has been shown to induce neurotoxicity in primary neurons and dopaminergic neuron degeneration in vivo. Two therapeutic approaches targeting LRRK2 (an antisense oligonucleotide and a kinase inhibitor) are currently in clinical trials for Parkinson's disease.

The role of Rab9 in viral replication also presents therapeutic opportunities. The crystal structure of Rab9 was characterized as part of a structure-based drug design program because Rab9 has been identified as a key cellular component for HIV-1, Ebola, Marburg, and measles virus replication [chen-2004-rab9-structure-abstract]. This suggests that small molecule inhibitors targeting Rab9 could potentially serve as broad-spectrum antiviral agents, though no such compounds have yet advanced to clinical development.

RAB9B is associated through chromosomal deletion with Pelizaeus-Merzbacher Disease and Spastic Paraplegia 2, X-Linked, though the primary causative gene in these disorders is PLP1 rather than RAB9B itself [ohira-2012-plp1-rab9b-deletion-abstract]. The functional consequences of RAB9B loss in these patients remain unclear due to potential compensation by RAB9A.

Open Questions

Despite substantial progress in understanding Rab9 biology, several important questions remain regarding RAB9B specifically:

1. Functional specificity versus redundancy: While RAB9B and RAB9A share effector interactions and presumably similar functions, are there contexts where RAB9B performs unique or specialized roles? The distinct tissue expression patterns (cardiac enrichment for RAB9B) suggest possible tissue-specific functions that remain to be characterized.

2. GEF and GAP identification: The specific GEF(s) responsible for activating RAB9B have not been definitively identified. Similarly, while RUTBC2 binds Rab9 as an effector, the GAP(s) that inactivate Rab9 proteins remain incompletely characterized.

3. LRRK2 phosphorylation consequences: While RAB9B is phosphorylated by LRRK2, the specific functional consequences of this modification for RAB9B activity and localization have not been extensively studied. Understanding this relationship may provide insights into Parkinson's disease pathogenesis.

4. Relative contributions to autophagy: The role of Rab9 in non-canonical autophagy has been established, but whether RAB9A and RAB9B contribute differentially to this pathway remains unknown.

5. Cardiac function: Given the enhanced expression of RAB9B in cardiac tissue, particularly in intercalated discs of heart myocytes, does RAB9B play specific roles in cardiac physiology or pathology?

6. Consequences of RAB9B loss: Patients with deletions of both PLP1 and RAB9B exist, but isolating the contribution of RAB9B loss from the dominant PLP1 phenotype is challenging. Generation of RAB9B-specific knockout models would help clarify the physiological requirements for this gene.

7. Neural cell-type specific roles: While RAB9A is enriched in oligodendrocytes, RAB9B shows a mixed neuronal expression pattern. The functional significance of this differential distribution in the nervous system warrants investigation.

References

1. [chen-2004-rab9-structure-abstract] Chen L, DiGiammarino E, Zhou XE, Wang Y, Toh D, Hodge TW, Meehan EJ. High resolution crystal structure of human Rab9 GTPase: a novel antiviral drug target. J Biol Chem. 2004 Sep 17;279(38):40204-8. PMID: 15263003. DOI: 10.1074/jbc.M407114200. PDB: 1WMS.

2. [barbero-2002-rab9-visualization-abstract] Barbero P, Bittova L, Bhattacharya S (Pfeffer lab). Visualization of Rab9-mediated vesicle transport from endosomes to the trans-Golgi in living cells. J Cell Biol. 2002;156(3):511-8. PMID: 11827983. PMCID: PMC2173336.

3. [ganley-2004-rab9-endosome-size-abstract] Ganley IG, Carroll K, Hanna L (Pfeffer lab). Rab9 GTPase Regulates Late Endosome Size and Requires Effector Interaction for Its Stability. Mol Biol Cell. 2004;15(12):5420-30. PMID: 15456905. PMCID: PMC532021. DOI: 10.1091/mbc.e04-08-0747.

4. [reddy-2006-gcc185-abstract] Reddy JV et al. A Functional Role for the GCC185 Golgin in Mannose 6-Phosphate Receptor Recycling. Mol Biol Cell. 2006;17(10):4353-63. PMID: 16885419. PMCID: PMC1635343. DOI: 10.1091/mbc.e06-02-0153.

5. [shu-2012-rutbc2-abstract] Shu DL, Lu P et al. RUTBC2 Protein, a Rab9A Effector and GTPase-activating Protein for Rab36. J Biol Chem. 2012;287(26):22333-40. PMID: 22637480. PMCID: PMC3391118. DOI: 10.1074/jbc.M112.358127.

6. [wu-2014-rab9a-rutbc2-structure-abstract] Wu M, Gan Y et al. Crystal Structure of the Rab9A-RUTBC2 RBD Complex Reveals the Molecular Basis for the Binding Specificity of Rab9A with RUTBC2. Structure. 2014;22(10):1408-20. PMID: 25220469. DOI: 10.1016/j.str.2014.08.005.

7. [steger-2016-lrrk2-rab-phosphoproteomics-abstract] Steger M, Tonelli F, Ito G et al. Phosphoproteomics reveals that Parkinson's disease kinase LRRK2 regulates a subset of Rab GTPases. eLife. 2016;5:e12813. PMID: 26824392. PMCID: PMC4769169. DOI: 10.7554/eLife.12813.

8. [nishida-2009-alternative-autophagy-abstract] Nishida Y, Arakawa S, Fujitani K et al. Discovery of Atg5/Atg7-independent alternative macroautophagy. Nature. 2009;461(7264):654-8. PMID: 19794493. DOI: 10.1038/nature08455.

9. [stenmark-2001-lysosome-biogenesis-abstract] Riederer MA, Lehner PJ et al. Lysosome biogenesis requires Rab9 function and receptor recycling from endosomes to the trans-Golgi network. J Cell Biol. 1994;125(3):573-82. PMID: 7909812. DOI: 10.1083/jcb.125.3.573.

10. [hanna-2002-tip47-rab9-abstract] Hanna L, Carroll K (Pfeffer lab). Purification and Analysis of TIP47 Function in Rab9-Dependent Mannose 6-Phosphate Receptor Trafficking. Methods Enzymol. 2006;403:191-205. PMID: 16473602. DOI: 10.1016/S0076-6879(05)03016-2.

11. [pfeffer-2009-multiple-routes-abstract] Pfeffer SR. Multiple routes of protein transport from endosomes to the trans Golgi network. FEBS Lett. 2009;583(23):3811-6. PMID: 19879873. PMCID: PMC2787657. DOI: 10.1016/j.febslet.2009.10.075.

12. [ohira-2012-plp1-rab9b-deletion-abstract] Ohira M, Nagata Y et al. Clinical and genetic characterization of a 2-year-old boy with complete PLP1 deletion. Brain Dev. 2012;34(10):853-7. DOI: 10.1016/j.braindev.2012.01.013.

13. [ganley-2006-npc-cholesterol-abstract] Ganley IG, Pfeffer SR. Cholesterol accumulation sequesters Rab9 and disrupts late endosome function in NPC1-deficient cells. J Biol Chem. 2006;281(26):17890-9. PMID: 16644737. PMCID: PMC3650718. DOI: 10.1074/jbc.M601679200.

14. [uniprot-q9np90-rab9b] UniProt Consortium. UniProtKB entry Q9NP90 - RAB9B. https://www.uniprot.org/uniprotkb/Q9NP90/entry

15. [human-protein-atlas-rab9b] Human Protein Atlas. RAB9B protein expression summary. https://www.proteinatlas.org/ENSG00000123570-RAB9B

Citations

1. barbero-2002-rab9-visualization-abstract.md
2. chen-2004-rab9-structure-abstract.md
3. ganley-2004-rab9-endosome-size-abstract.md
4. ganley-2006-npc-cholesterol-abstract.md
5. hanna-2002-tip47-rab9-abstract.md
6. human-protein-atlas-rab9b.md
7. nishida-2009-alternative-autophagy-abstract.md
8. ohira-2012-plp1-rab9b-deletion-abstract.md
9. pfeffer-2009-multiple-routes-abstract.md
10. reddy-2006-gcc185-abstract.md
11. shu-2012-rutbc2-abstract.md
12. steger-2016-lrrk2-rab-phosphoproteomics-abstract.md
13. stenmark-2001-lysosome-biogenesis-abstract.md
14. uniprot-q9np90-rab9b.md
15. wu-2014-rab9a-rutbc2-structure-abstract.md

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

Plan and verification
- Identity check: The target is human RAB9B (UniProt Q9NP90), a small GTPase of the Rab family. Rab9 proteins regulate transport between late endosomes and the trans-Golgi network (TGN). The literature recognizes two human isoforms, Rab9A and Rab9B; most mechanistic work has focused on Rab9A, with functional inferences extended to Rab9B as a close paralog. Where evidence is Rab9A-specific, this is stated, and implications for Rab9B are noted cautiously (ng2012rabgtpasesregulating pages 4-6).

1) Key concepts and definitions with current understanding
- Protein class and domains: RAB9B encodes a small Ras-related GTPase (Rab subfamily) that cycles between GDP- and GTP-bound states to control vesicular trafficking steps. Like other Rabs, its switch I/II regions mediate GTP-dependent effector binding; effector recognition via these regions is exemplified biochemically for Rab9’s interaction with effectors (shown for Rab9A) (Journal of Biological Chemistry, 2010-03; https://doi.org/10.1074/jbc.M109.069088) (kloer2010assemblyofthe pages 8-9).
- Canonical pathway: Rab9 family GTPases mediate retrograde trafficking from late endosomes to the TGN, classically to recycle cation-independent mannose-6-phosphate receptor (CI-M6PR), which retrieves lysosomal hydrolases. TIP47 acts as a cargo adaptor that binds M6PR cytosolic tails and partners with Rab9; the TGN golgin/tether GCC185 functions as a Rab9 effector to capture incoming vesicles. These functions are well reviewed, establishing the Rab9 pathway’s role in endosome→TGN recycling (Cell Biochemistry and Function, 2012-08; https://doi.org/10.1002/cbf.2827) (ng2012rabgtpasesregulating pages 4-6).
- Subcellular localization: Rab9 family proteins localize to late endosomes and can be detected on lysosomal membranes; perturbation of Rab9A or Rab9B (siRNA) impacts MPR/TGN46 distribution, consistent with roles at the late endosome–TGN interface (Journal of Cell Biology, 2010-10; https://doi.org/10.1083/jcb.201008051) (yoshimura2010familywidecharacterizationof pages 9-10).

2) Recent developments and latest research (prioritize 2023–2024)
- Targeted 2023–2024, human RAB9B-specific primary studies are sparse. Contemporary work continues to place the Rab9 pathway at the center of endosome→TGN sorting, but most new mechanistic dissection still uses Rab9A. Cell-context specificity in innate immunity highlights that Rab9 is recruited to pathogen vacuoles and can modulate antimicrobial trafficking; in macrophages, Rab9 is not required for Rab32/BLOC-3–dependent Salmonella killing, refining older models that placed Rab9 upstream of Rab32 (Frontiers in Cellular and Infection Microbiology, 2020-12; https://doi.org/10.3389/fcimb.2020.581024) (balci2020varpandrab9 pages 5-8). This underscores pathway rewiring across cell types and cautions against assuming a universal Rab9B role in antimicrobial vacuolar traffic.
- Systems-scale GEF mapping remains a cornerstone for Rab9 paralogs: DENN-domain family screens (including siRNA to Rab9A, Rab9B and DENND2 paralogs) demonstrated effects on MPR distribution and support DENND-family GEFs in the Rab9 axis; these findings continue to guide GEF assignments in current databases and reviews (Journal of Cell Biology, 2010-10; https://doi.org/10.1083/jcb.201008051) (yoshimura2010familywidecharacterizationof pages 9-10).

3) Current applications and real-world implementations
- Lysosome biogenesis and enzyme delivery: Because CI-M6PR recycling determines lysosomal hydrolase trafficking, Rab9 pathway integrity is a practical readout in studies of lysosomal storage and toxin routing. TIP47–Rab9–GCC185 interactions are used experimentally to manipulate retrograde traffic and interpret toxin susceptibility assays that depend on endosome→TGN transport (reviewed in Cell Biochemistry and Function, 2012-08; https://doi.org/10.1002/cbf.2827) (ng2012rabgtpasesregulating pages 4-6).
- Infection biology: In macrophages, Rab9 is recruited to Salmonella-containing vacuoles, but depletion did not impair Rab32/BLOC-3–dependent killing, informing host-directed therapeutic strategies that target distinct Rab circuits without compromising antimicrobial functions (Frontiers in Cellular and Infection Microbiology, 2020-12; https://doi.org/10.3389/fcimb.2020.581024) (balci2020varpandrab9 pages 5-8).

4) Expert opinions and analysis from authoritative sources
- Effector recognition and specificity: The biochemical paradigm that Rab effectors recognize switch I/II in the GTP-bound state is clearly demonstrated for Rab9A with BLOC-3/HPS4. High-affinity binding (KD ~82 nM for BLOC-3–Rab9A-GTP) indicates a robust effector interaction surface; given the close paralogy, this frames expectations for Rab9B effector engagement, pending direct measurements (Journal of Biological Chemistry, 2010-03; https://doi.org/10.1074/jbc.M109.069088) (kloer2010assemblyofthe pages 8-9).
- Pathway architecture: Authoritative reviews position Rab9 as central to late endosome–TGN retrograde traffic, coordinating cargo adaptors (TIP47), TGN tethers (GCC185), and SNARE machinery. These analyses remain the standard interpretive framework for Rab9 paralogs including RAB9B (Cell Biochemistry and Function, 2012-08; https://doi.org/10.1002/cbf.2827) (ng2012rabgtpasesregulating pages 4-6).

5) Relevant statistics and data from recent studies
- Effector affinity: BLOC-3 (HPS1–HPS4 heterodimer) binds Rab9A-GTP with KD ≈ 82 ± 11 nM; a truncated BLOC-3 variant binds with KD ≈ 203 ± 15 nM, mapping to Rab9 switch I/II (Journal of Biological Chemistry, 2010-03; https://doi.org/10.1074/jbc.M109.069088) (kloer2010assemblyofthe pages 8-9).
- Functional depletion outcomes: In HeLa cells, siRNA targeting Rab9A, Rab9B, and DENND2 family members perturbed MPR/TGN46 localization, supporting a role for both Rab9 isoforms in receptor recycling; Rab9-tagged constructs localized to lysosome membranes in these assays (Journal of Cell Biology, 2010-10; https://doi.org/10.1083/jcb.201008051) (yoshimura2010familywidecharacterizationof pages 9-10).
- Pathogen vacuole recruitment: GFP-Rab9 is recruited to Salmonella-containing vacuoles; nonetheless, Rab9 knockdown did not diminish Rab32/BLOC-3–dependent killing in macrophages, indicating pathway divergence by cell type (Frontiers in Cellular and Infection Microbiology, 2020-12; https://doi.org/10.3389/fcimb.2020.581024) (balci2020varpandrab9 pages 5-8).

Detailed functional annotation for RAB9B (human)
- Primary function: RAB9B is a Rab GTPase implicated in retrograde transport from late endosomes to the TGN, acting in retrieval of CI-M6PR and associated cargo. Core components of this route include the cargo adaptor TIP47 and the TGN tether GCC185; their cooperation facilitates vesicle capture and fusion at the TGN. While most direct mechanistic evidence is for Rab9A, siRNA-based functional data indicate Rab9B participates in the same pathway in human cells (Cell Biochemistry and Function, 2012-08; https://doi.org/10.1002/cbf.2827; Journal of Cell Biology, 2010-10; https://doi.org/10.1083/jcb.201008051) (ng2012rabgtpasesregulating pages 4-6, yoshimura2010familywidecharacterizationof pages 9-10).
- Subcellular localization: Late endosomes/lysosomes and vesicles en route to the TGN; Rab9 family proteins can be visualized on lysosomal membranes and late endosomal carriers in human cells (Journal of Cell Biology, 2010-10; https://doi.org/10.1083/jcb.201008051; Cell Biochemistry and Function, 2012-08; https://doi.org/10.1002/cbf.2827) (yoshimura2010familywidecharacterizationof pages 9-10, ng2012rabgtpasesregulating pages 4-6).
- Effectors and regulators:
• Effectors: TIP47 (cargo adaptor) and GCC185 (TGN tether) are established Rab9 effectors coordinating MPR recycling (Cell Biochemistry and Function, 2012-08; https://doi.org/10.1002/cbf.2827) (ng2012rabgtpasesregulating pages 4-6).
• BLOC-3 (HPS1–HPS4): Biochemically validated Rab9A effector with high-affinity, GTP-dependent binding via Rab switch I/II. This positions the HPS1/4 complex as a Rab9 pathway effector relevant to lysosome-related organelle biogenesis; applicability to Rab9B is plausible but not yet directly quantified (Journal of Biological Chemistry, 2010-03; https://doi.org/10.1074/jbc.M109.069088) (kloer2010assemblyofthe pages 8-9).
• GEFs: Family-wide DENN screens and parallel depletion of DENND2 and Rab9A/B support DENN-domain GEFs acting upstream in the Rab9 axis; specific DENND2 involvement was inferred from MPR redistribution upon knockdown (Journal of Cell Biology, 2010-10; https://doi.org/10.1083/jcb.201008051) (yoshimura2010familywidecharacterizationof pages 9-10).
- Distinctions from RAB9A: Experimental literature is heavily Rab9A-biased; nevertheless, siRNA evidence indicates that Rab9B contributes to the same endosome→TGN pathway in human cells. Cell-type expression differences exist; in macrophages, Rab9b transcripts were reported as barely detected, suggesting tissue/cell-type variability that may underlie experimental dependence on Rab9A versus Rab9B (Frontiers in Cellular and Infection Microbiology, 2020-12; https://doi.org/10.3389/fcimb.2020.581024; Journal of Cell Biology, 2010-10; https://doi.org/10.1083/jcb.201008051) (balci2020varpandrab9 pages 5-8, yoshimura2010familywidecharacterizationof pages 9-10).
- Roles in autophagy/mitophagy: Direct, human RAB9B-specific evidence in 2020–2024 primary literature was not identified in the sources retrieved here. Given the Rab9 pathway’s endolysosomal focus, some reviews discuss potential intersections with degradative pathways, but precise Rab9B roles require more direct study; thus, no specific claim is made here absent primary support (ng2012rabgtpasesregulating pages 4-6).
- Disease/phenotype associations: Rab9 pathway dysfunction affects lysosomal enzyme trafficking and can modulate pathogen handling. In macrophages, Rab9 recruitment to SCVs is evident, but Rab9 is dispensable for Rab32/BLOC‑3–mediated killing, narrowing its disease-relevant role in certain innate contexts (Frontiers in Cellular and Infection Microbiology, 2020-12; https://doi.org/10.3389/fcimb.2020.581024) (balci2020varpandrab9 pages 5-8). More granular, RAB9B-specific human genetic associations were not supported by the retrieved, citable primary sources.

Limitations and open questions
- The majority of precise biochemical data (e.g., BLOC-3 binding kinetics) are for Rab9A, and high-confidence, Rab9B-specific effector/GEF kinetics remain to be established. Cell-type expression differences (e.g., low Rab9b transcript in macrophages) may produce divergent dependencies across tissues and should be mapped systematically (Frontiers in Cellular and Infection Microbiology, 2020-12; https://doi.org/10.3389/fcimb.2020.581024) (balci2020varpandrab9 pages 5-8).

Conclusion
Human RAB9B is a Rab family small GTPase that contributes to endosome-to-TGN retrograde trafficking, particularly CI-M6PR recycling, by engaging canonical Rab9 effectors including cargo adaptor TIP47 and the TGN tether GCC185, localizing to late endosomal/lysosomal membranes and retrograde carriers. Rab9 pathway regulation involves DENN-domain GEFs; BLOC-3/HPS4 is a high-affinity Rab9 effector demonstrated for Rab9A and relevant to lysosome-related organelle biogenesis. In innate immune cells, Rab9 is recruited to pathogen vacuoles but is dispensable for Rab32/BLOC-3-dependent killing, emphasizing cell-context specificity. While recent, Rab9B-specific human studies are limited, convergent functional and localization data support a conserved role alongside Rab9A in maintaining lysosomal enzyme recycling and endosomal–Golgi homeostasis (Journal of Biological Chemistry, 2010-03; https://doi.org/10.1074/jbc.M109.069088; Journal of Cell Biology, 2010-10; https://doi.org/10.1083/jcb.201008051; Cell Biochemistry and Function, 2012-08; https://doi.org/10.1002/cbf.2827; Frontiers in Cellular and Infection Microbiology, 2020-12; https://doi.org/10.3389/fcimb.2020.581024) (kloer2010assemblyofthe pages 8-9, yoshimura2010familywidecharacterizationof pages 9-10, ng2012rabgtpasesregulating pages 4-6, balci2020varpandrab9 pages 5-8).

References

1. (ng2012rabgtpasesregulating pages 4-6): Ee Ling Ng, Bin Qi Gan, Fanny Ng, and Bor Luen Tang. Rab gtpases regulating receptor trafficking at the late endosome–lysosome membranes. Cell Biochemistry and Function, 30:515-523, Aug 2012. URL: https://doi.org/10.1002/cbf.2827, doi:10.1002/cbf.2827. This article has 57 citations and is from a peer-reviewed journal.

2. (kloer2010assemblyofthe pages 8-9): Daniel P. Kloer, Raul Rojas, Viorica Ivan, Kengo Moriyama, Thijs van Vlijmen, Namita Murthy, Rodolfo Ghirlando, Peter van der Sluijs, James H. Hurley, and Juan S. Bonifacino. Assembly of the biogenesis of lysosome-related organelles complex-3 (bloc-3) and its interaction with rab9. Journal of Biological Chemistry, 285:7794-7804, Mar 2010. URL: https://doi.org/10.1074/jbc.m109.069088, doi:10.1074/jbc.m109.069088. This article has 122 citations and is from a domain leading peer-reviewed journal.

3. (yoshimura2010familywidecharacterizationof pages 9-10): Shin-ichiro Yoshimura, Andreas Gerondopoulos, Andrea Linford, Daniel J. Rigden, and Francis A. Barr. Family-wide characterization of the denn domain rab gdp-gtp exchange factors. The Journal of Cell Biology, 191:367-381, Oct 2010. URL: https://doi.org/10.1083/jcb.201008051, doi:10.1083/jcb.201008051. This article has 432 citations.

4. (balci2020varpandrab9 pages 5-8): Arda Balci, Virtu Solano-Collado, Massimiliano Baldassarre, and Stefania Spanò. Varp and rab9 are dispensable for the rab32/bloc-3 dependent salmonella killing. Frontiers in Cellular and Infection Microbiology, Dec 2020. URL: https://doi.org/10.3389/fcimb.2020.581024, doi:10.3389/fcimb.2020.581024. This article has 7 citations and is from a poor quality or predatory journal.

Citations

1. ng2012rabgtpasesregulating pages 4-6
2. kloer2010assemblyofthe pages 8-9
3. yoshimura2010familywidecharacterizationof pages 9-10
4. https://doi.org/10.1074/jbc.M109.069088
5. https://doi.org/10.1002/cbf.2827
6. https://doi.org/10.1083/jcb.201008051
7. https://doi.org/10.3389/fcimb.2020.581024
8. https://doi.org/10.1002/cbf.2827;
9. https://doi.org/10.1083/jcb.201008051;
10. https://doi.org/10.3389/fcimb.2020.581024;
11. https://doi.org/10.1074/jbc.M109.069088;
12. https://doi.org/10.1002/cbf.2827,
13. https://doi.org/10.1074/jbc.m109.069088,
14. https://doi.org/10.1083/jcb.201008051,
15. https://doi.org/10.3389/fcimb.2020.581024,

Overview of RAB9B: A Rab Family GTPase

RAB9B (Ras-related protein Rab-9B, UniProt Q9NP90) is a human small GTPase in the Rab subfamily of the RAS superfamily. Like other Rab proteins, RAB9B functions as a molecular switch cycling between an inactive GDP-bound state and an active GTP-bound state (www.genecards.org). In the GTP-bound form, RAB9B recruits specific effector proteins to membranes, thereby directing vesicle formation, movement, tethering, and fusion (www.genecards.org). Enzymatically, RAB9B hydrolyzes GTP to GDP (EC 3.6.5.2), a reaction common to all GTPases that underlies its switch mechanism (www.genecards.org) (www.genecards.org). This protein belongs to the Rab9 subfamily, which in mammals has two isoforms: Rab9A and Rab9B (also historically called Rab9L for “Rab-9-like”) (pmc.ncbi.nlm.nih.gov). Rab9A is generally considered the prototypical “Rab9” and performs the major housekeeping functions, while Rab9B is a paralogous isoform with very high sequence similarity (on the order of ~90% identity) and likely overlapping function (pmc.ncbi.nlm.nih.gov). RAB9B was first identified around 2000 as a new Rab9-like cDNA on human chromosome Xq22 (www.nature.com), and its transcript is ubiquitously expressed across tissues. For example, mRNA profiling shows RAB9B expression in heart (~9 RPKM), brain (~6 RPKM), and at lower levels in many other tissues (www.ncbi.nlm.nih.gov), indicating a broad if moderate expression pattern. Notably, evolutionary studies find that Rab9A tends to be more abundantly expressed than Rab9B across species (pmc.ncbi.nlm.nih.gov). This suggests Rab9A carries the bulk of Rab9-related activity, whereas Rab9B may serve a more specialized or context-specific role, despite their biochemical similarity (pmc.ncbi.nlm.nih.gov).

Structurally, RAB9B is a ~201-amino-acid globular GTP-binding protein containing the conserved P-loop NTP-binding domain and characteristic switch regions of Rab GTPases (www.genecards.org). It shares all the signature G-box motifs (G1-G5) that mediate guanine nucleotide binding and hydrolysis (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). RAB9B’s C-terminus contains lipidation sites (CAAX motif) for prenylation, anchoring the protein to cellular membranes when active – a common feature required for Rab membrane association. Importantly, RAB9B’s primary amino acid sequence and domain architecture closely mirror that of Rab9A. The two Rab9 isoforms arose from a gene duplication in early vertebrate evolution (pmc.ncbi.nlm.nih.gov), and their coding sequences are highly conserved. Key functional domains (e.g. the Switch I/II regions that bind effectors) are essentially intact in RAB9B, implying it can interact with many of the same partners as Rab9A. Consistent with this, RAB9B is classified in gene ontology as participating in “Rab protein signal transduction” and “intracellular protein transport”, with localization to the late endosome, lysosome, cytoplasmic vesicles, and trans-Golgi network (TGN) membranes (www.proteinatlas.org) (www.proteinatlas.org). These annotations, largely inferred from homology to Rab9A, set the expectation that RAB9B is a regulator of late endosomal trafficking routes. Below, we detail the current understanding of RAB9B’s functions, interactions, localization, and roles in cellular physiology, highlighting both foundational concepts and recent research findings.

Role in Endosome-to-Golgi Transport and Lysosomal Enzyme Traffic

RAB9B’s primary established function is mediating retrograde transport from late endosomes to the trans-Golgi network (TGN). This pathway is crucial for recycling certain cargo receptors and maintaining lysosome function. In particular, Rab9 (the family including A/B) controls the retrieval of mannose-6-phosphate receptors (MPRs) from late endosomes back to the Golgi (pmc.ncbi.nlm.nih.gov). MPRs are the receptors that carry newly made acid hydrolase enzymes to endosomes; after dropping off their cargo, MPRs must be returned to the Golgi for reuse. Rab9 proteins facilitate this recycling by recruiting effectors that sort MPRs into budding vesicles destined for the TGN (pmc.ncbi.nlm.nih.gov). A key Rab9 effector in this process is TIP47 (also known as M6PRBP1, the 47-kDa tail-interacting protein) (pmc.ncbi.nlm.nih.gov). Active GTP-bound Rab9 on late endosomal membranes binds TIP47, and TIP47 in turn recognizes the cytosolic tail of mannose-6-phosphate receptors (pmc.ncbi.nlm.nih.gov). Through this Rab9–TIP47 complex, late endosomes selectively capture MPR cargo and form transport vesicles (pmc.ncbi.nlm.nih.gov). In essence, Rab9 and TIP47 act as a cargo-selection device for retrograde vesicles, ensuring that MPRs (and possibly other receptors) are packaged for return to the Golgi (pmc.ncbi.nlm.nih.gov). This mechanism was demonstrated in classic studies (e.g. Science 2001) showing that Rab9 is required for TIP47 to stably associate with MPR tails and retrieve them from endosomes (pmc.ncbi.nlm.nih.gov). In cells lacking functional Rab9 or TIP47, MPRs fail to recycle and instead get misrouted or degraded, leading to the loss of lysosomal enzymes to the extracellular space (since MPRs aren’t there to recycle them) (pmc.ncbi.nlm.nih.gov). Thus, Rab9-dependent trafficking is indispensable for proper lysosome enzyme targeting. RAB9B, being highly similar to Rab9A, is thought to perform an equivalent role in this pathway** (pmc.ncbi.nlm.nih.gov). Indeed, a recent analysis noted that “Rab9A is a general Rab9 molecule, and Rab9B appears likely to perform a similar function” in endosome-to-Golgi transport (pmc.ncbi.nlm.nih.gov). Both isoforms localize to late endosomal compartments around the perinuclear region and support the export of cargo from endosomes (pubmed.ncbi.nlm.nih.gov).

Subcellular localization studies confirm that Rab9 proteins (A and B) reside on late endosomes and on the TGN membrane. RAB9B, like Rab9A, is predominantly found on cytoplasmic vesicles positive for late endosome/lysosome markers (www.proteinatlas.org). It cycles between the cytosol (GDP-bound form, often escorted by GDI proteins) and the cytosolic face of late endosome membranes (GTP-bound form). From the late endosome, Rab9-positive vesicular/tubular carriers move along microtubules toward the Golgi. In fact, Rab9 is required for late endosome motility to the TGN (pubmed.ncbi.nlm.nih.gov). A 2021 structural biology study provided insight into how Rab9-linked vesicles are physically transported: it identified NDE1/NDEL1 (Nuclear Distribution Element 1 and its homolog) as direct effectors of Rab9 that connect endosomes to the dynein motor complex (pubmed.ncbi.nlm.nih.gov). Specifically, GTP-bound Rab9A/B can bind NDE1/NDEL1, which in turn attach to the dynein–dynactin motor machinery, thereby “tethering Rab9-associated late endosomes to the dynein motor for their retrograde transport to the TGN.” (pubmed.ncbi.nlm.nih.gov). The authors solved the crystal structure of Rab9A–GTP in complex with the NDE1 Rab9-binding domain, confirming this interaction at the molecular level (pubmed.ncbi.nlm.nih.gov). Mutations that disrupt Rab9’s binding to NDE1 prevent late endosomes from engaging dynein, resulting in failures in cargo delivery to the Golgi (pubmed.ncbi.nlm.nih.gov). This discovery fills an important gap in the trafficking model: once Rab9 (including RAB9B) selects cargo via effectors like TIP47, it likely hands off the vesicle to the dynein motor through NDE1/NDEL1, ensuring minus-end directed transport along microtubules (pubmed.ncbi.nlm.nih.gov) (pubmed.ncbi.nlm.nih.gov). In summary, RAB9B functions at the nexus of cargo selection and vesicle motility in the late endosome-to-Golgi route – it gathers the correct cargo (e.g. MPRs) and then helps propel the vesicle toward the TGN for fusion.

Consistent with this role, gene ontology and cell imaging data place RAB9B at late endosomes, lysosomes, and the TGN. For example, the Human Protein Atlas notes RAB9B in the “late endosome” and “lysosome” categories and in “retrograde transport, endosome to Golgi” (GO:0042147) (www.proteinatlas.org) (www.proteinatlas.org). Experimentally, Rab9-containing vesicles are often observed clustered near the Golgi region (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). When Rab9 function is lost (e.g. via siRNA knockdown), late endosome traffic jams occur: cargo that should return to the TGN gets stuck in endosomes. In one illustrative example, silencing Rab9 expression was shown to dramatically inhibit HIV-1 assembly because the viral Env protein became trapped in endosomes instead of reaching the plasma membrane (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). The same study noted that knockdown of Rab9 (and its effectors TIP47 and p40) impaired the exit of internalized proteins from late endosomes (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). This reinforces that Rab9 (including Rab9B) normally facilitates “trafficking out of the late endosome to the TGN” – a step required not just for MPR recycling but for any process that needs endosome-to-Golgi sorting (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov).

Interactions and Effectors: Partners in Vesicle Trafficking

RAB9B exerts its effects by recruiting multiple effector proteins to vesicle membranes. As mentioned, TIP47 (M6PRBP1) is a key effector binding Rab9 on late endosomes, mediating cargo recognition (MPR sorting) (pmc.ncbi.nlm.nih.gov). Another important effector is the Rab9 effector protein with Kelch repeats, known as p40 (RABEPK). Rab9–p40 interaction occurs at the TGN, where p40 helps tether incoming Rab9-positive vesicles (pmc.ncbi.nlm.nih.gov). It has been proposed that p40 and Rab9 form a complex at the TGN to capture and fuse incoming endosome-derived vesicles (pmc.ncbi.nlm.nih.gov). Indeed, membrane anchoring of p40 at the TGN depends on Rab9, and together they promote efficient delivery of cargo like MPRs into the Golgi compartments (pmc.ncbi.nlm.nih.gov). Additionally, PIKfyve, a phosphatidylinositol-3-phosphate 5-kinase, works upstream to generate PI(3,5)P₂ on endosomes, a lipid needed for Rab9-TIP47 function. In cellular studies, silencing PIKfyve phenocopies Rab9 knockdown, pointing to PIKfyve’s role in preparing endosome membranes for Rab9-mediated export (pmc.ncbi.nlm.nih.gov). RAB9B likely utilizes the same effectors: there is no evidence for unique RAB9B-only partners, and the effector-binding surfaces of Rab9A and Rab9B are practically identical. In fact, the 2021 NDE1 study explicitly showed Rab9B (in addition to Rab9A) binds NDE1/NDEL1, underlining that Rab9B is fully competent in effector interactions (pubmed.ncbi.nlm.nih.gov) (pubmed.ncbi.nlm.nih.gov). The term “Rab9” in such contexts generally includes both isoforms, especially if both are co-expressed.

One interesting nuance is that Rab9A and Rab9B may have partially redundant but not completely overlapping expression, so certain cell types might rely on one isoform over the other. For instance, in oligodendrocyte-lineage cells of the brain, Rab9A is highly expressed whereas Rab9B is not, suggesting Rab9A carries out the Rab9 functions in those cells (pmc.ncbi.nlm.nih.gov). Conversely, other cell types might express Rab9B sufficiently to compensate if Rab9A is low. However, when both are present, they likely interact with the same pool of effectors. This redundancy is supported by the observation that ectopic Rab9B can substitute for Rab9A in some experimental systems (although direct comparative studies are limited). In summary, RAB9B interacts with the canonical Rab9 effectors – TIP47, p40, NDE1/NDEL1, and others – to orchestrate vesicle transport between endosomes and Golgi. By similarity to Rab9A, it also may bind known regulators such as GDP dissociation inhibitor (GDI), which scavenges inactive Rab9 in the cytosol, and specific GTPase-activating proteins (GAPs) and guanine exchange factors (GEFs) that toggle its nucleotide state. (The exact GEF for Rab9A/B remains not fully clarified, but candidates have been suggested in the context of endosomal compartments (pmc.ncbi.nlm.nih.gov).) Additionally, emerging evidence points to cross-talk with the retromer complex: Rab9 and retromer (a coat complex for endosome-to-Golgi tubules) can cooperate in retrograde transport (pmc.ncbi.nlm.nih.gov). In Drosophila, for example, Rab9 and retromer jointly regulate recycling of certain lumenal proteins from endosomes (pmc.ncbi.nlm.nih.gov). It is conceivable that RAB9B, like Rab9A, recruits or stabilizes retromer on endosomal membranes for efficient cargo sorting.

Beyond the classic partners, recent research has uncovered new RAB9B interactors linking it to autophagy pathways. A 2024 study showed that TMEM9, a lysosomal membrane protein, interacts with the autophagy protein Beclin1 in a Rab9-dependent manner (pubmed.ncbi.nlm.nih.gov). TMEM9 can bind Beclin1 and displace its inhibitor Bcl-2, thereby activating a Rab9-dependent, alternative autophagy pathway (pubmed.ncbi.nlm.nih.gov). Notably, TMEM9 colocalizes with Rab9-positive late endosomes/lysosomes and this interaction triggers a form of autophagy that does not use the canonical LC3 conjugation system (termed LC3-independent autophagy) (pubmed.ncbi.nlm.nih.gov). In this process, Rab9 and Beclin1 drive the formation of double-membrane autophagosomes from late endosomal membranes when the usual autophagy genes (ATG5/ATG7) are disabled (www.nature.com). Thus, Rab9B appears to play a role in “back-up” autophagy pathways, partnering with TMEM9–Beclin1 to induce autophagosome formation under certain stress conditions (pubmed.ncbi.nlm.nih.gov). This aligns with earlier findings (Nishida et al. 2009) that Rab9 is required for a non-canonical autophagy route that helps cells survive when the primary autophagy machinery is compromised (www.nature.com). The involvement of Rab9B in such pathways broadens its functional repertoire beyond just protein sorting – it can also contribute to organelle remodeling and degradation processes.

Expression Patterns and Isoform-Specific Insight

RAB9B is encoded on the X chromosome (Xq22.2) (www.ncbi.nlm.nih.gov), in close proximity to the PLP1 gene (which encodes proteolipid protein 1, a critical myelin protein). Intriguingly, the RAB9B and PLP1 genes are arranged in an antiparallel orientation (head-to-head) in both human and mouse genomes (pmc.ncbi.nlm.nih.gov). This genomic context has clinical significance: a reported case of an X-linked leukodystrophy (Pelizaeus–Merzbacher disease, PMD) involved a patient with a complete PLP1 gene deletion that also encompassed RAB9B, and the child presented relatively mild disease (pmc.ncbi.nlm.nih.gov). Researchers have speculated that loss of RAB9B alongside PLP1 might modulate the severity of myelin defects (pmc.ncbi.nlm.nih.gov). One hypothesis is that deleting RAB9B (which is normally expressed in the brain) could reduce some detrimental accumulation of membranes or proteins in oligodendrocytes, partially compensating for PLP1 loss (pmc.ncbi.nlm.nih.gov). While this remains to be confirmed, it highlights that RAB9B’s expression in the brain and its genomic linkage to a myelin gene could be biologically relevant. Overall, RAB9B is widely expressed but typically at lower levels than RAB9A. Data from the Human Protein Atlas and other transcriptomic studies show that Rab9A has a more cell-type-enriched profile (e.g. high in oligodendrocytes), whereas Rab9B is expressed more evenly and without strong enrichment (pmc.ncbi.nlm.nih.gov). For example, in the brain, Rab9A is abundant in oligodendroglial cells, whereas Rab9B mRNA is relatively uniformly low across cell types (pmc.ncbi.nlm.nih.gov). This suggests that Rab9B might serve as a “baseline” Rab9 activity in many cells, but in some specialized cells (like myelinating glia or perhaps melanocytes), Rab9A is upregulated to meet higher trafficking demand.

It’s worth noting that RAB9B (Gene ID 51209) has only one known transcript and protein isoform in humans (www.ncbi.nlm.nih.gov), and it is classified as “Evidence at protein level” meaning the protein’s existence has been confirmed (e.g. by mass spectrometry) (www.proteinatlas.org). As a small GTPase, the protein is typically around 22.7 kDa in size (www.proteinatlas.org) and post-translationally geranylgeranylated at the C-terminus (allowing membrane attachment). There is no indication of alternatively spliced variants for RAB9B, unlike some other Rab family members. Regulation of RAB9B expression has not been as deeply characterized as Rab9A; however, one study in Aging Cell (2024) found that Rab9 protein levels increase in certain conditions like aging oocytes (see below), implying RAB9B expression can be dynamic in response to cellular stress or age (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). On the whole, the consensus is that RAB9B is constitutively expressed at a basal level in most tissues (with broad mRNA detection in >15 tissues (www.ncbi.nlm.nih.gov)), while RAB9A is the more variable, inducible isoform tuned to specific cellular needs (pmc.ncbi.nlm.nih.gov). This relationship mirrors other Rab duplicates (e.g. Rab7a/Rab7b, where Rab7b is the smaller player). The presence of two Rab9 isoforms in vertebrates likely provides a fail-safe and fine-tuning mechanism for critical trafficking routes, given the importance of the pathway for cell viability.

Biological Importance and Emerging Research (2023–2024)

Beyond its basal role in membrane traffic, RAB9B (and Rab9 generally) has been implicated in several physiological and pathological contexts, with a surge of recent research shedding light on new roles:

• Viral Infection and Host–Pathogen Interaction: Many enveloped viruses hijack the Rab9-dependent trafficking pathway to facilitate their assembly or egress. A landmark 2005 study by Murray et al. demonstrated that HIV-1, Ebola, Marburg, and measles viruses all require Rab9 function for efficient replication (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). Silencing Rab9 in host cells dramatically inhibited the production of these viruses (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). Mechanistically, HIV-1 was shown to utilize Rab9-mediated late endosome-to-TGN transport to sort its envelope glycoprotein (Env) into virions that bud at the cell surface (pmc.ncbi.nlm.nih.gov). When Rab9 or its effectors (TIP47, p40) were knocked down, HIV Env failed to be incorporated into budding particles, and virus release dropped sharply (pmc.ncbi.nlm.nih.gov). Similarly, gene-trap screens found Rab9 to be essential for filoviruses (Ebola/Marburg): Rab9 disruption allowed cells to survive otherwise-lethal infection (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). These viruses appear to initiate assembly on late endosomal membranes and then require Rab9-driven trafficking to deliver viral components to the plasma membrane for final budding (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). Interestingly, a non-enveloped virus (reovirus) was unaffected by Rab9 knockdown, highlighting that Rab9’s role is specific to enveloped virus pathways (pmc.ncbi.nlm.nih.gov). Collectively, these findings identify Rab9 as a potential broad-spectrum antiviral target – interfering with Rab9 function disrupts a late-endosomal egress route exploited by multiple viruses (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). Compounds that modulate Rab9 or its regulators are being explored in this context (patent literature has proposed Rab9 inhibitors to block viral replication) (patents.google.com). It is reasonable to assume RAB9B can substitute for Rab9A in these processes if expressed; thus, both isoforms might need to be suppressed for an antiviral effect. However, given Rab9A’s higher expression in typical cell lines used, it was likely the dominant player in those experiments. Future antiviral strategies may consider targeting RAB9B in tissues where it is the primary isoform.

• Neurobiology and Myelination: Rab9 has recently been linked to oligodendrocyte function and myelin-related disorders. Oligodendrocytes, which produce the myelin sheath in the CNS, highly express Rab9A (pmc.ncbi.nlm.nih.gov), and perturbations in trafficking can impact myelination. A 2024 study by Fukushima et al. reported a “unique role for Rab9 in oligodendroglial cell morphological changes.” (pmc.ncbi.nlm.nih.gov) In an oligodendroglial precursor cell line, knockdown of Rab9 (A/B) unexpectedly promoted differentiation: cells showed enhanced membrane extension and increased expression of myelination markers (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). Moreover, reducing Rab9 levels rescued the cells from ER-stress-induced defects in differentiation (ER stress is a known contributor to myelin disorders like Pelizaeus–Merzbacher disease) (pmc.ncbi.nlm.nih.gov). Notably, the Rab9 knockdown could “recover” the morphological deficits caused by a mutant PLP1 protein (the same gene adjacent to RAB9B on X) in a cellular model of PMD (pmc.ncbi.nlm.nih.gov). These findings suggest that Rab9 normally acts as a negative regulator of oligodendrocyte morphological maturation, perhaps by restraining membrane trafficking dynamics. By removing Rab9 brake, cells were able to extend processes and myelinate more effectively. The authors propose Rab9 as a novel therapeutic target for certain myelin diseases, as its inhibition showed beneficial effects at the cellular level (pmc.ncbi.nlm.nih.gov). Given RAB9B’s location and possible co-deletion in PMD cases (pmc.ncbi.nlm.nih.gov), one wonders if RAB9B loss might mildly mimic a therapeutic Rab9 knockdown in oligodendrocytes – possibly explaining the milder phenotype in the patient with a dual PLP1/RAB9B deletion. Further research is needed, but these insights broaden our view: Rab9 (and thus RAB9B) could influence cell differentiation processes and disease outcomes in the nervous system.

• Oocyte Aging and Reproductive Biology: Another 2024 study (Min Gao et al., published in Aging Cell) uncovered a role for Rab9 in female reproductive aging. The researchers found that RAB9 protein levels accumulate significantly in aging oocytes (egg cells) of both mice and humans, compared to young oocytes (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). Strikingly, this age-associated Rab9 elevation was linked to defects in oocyte meiosis: older oocytes with high Rab9 had more spindle assembly problems, chromosome misalignment, and failed to complete meiotic divisions properly (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). Rab9 overexpression in young oocytes could recreate some of these defects, while conversely, partial knockdown of Rab9 in old oocytes improved their maturation and reduced markers of cellular stress (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). The study showed that excess Rab9 triggers abnormal mitophagy (PINK1–PARKIN pathway activation) and elevates ROS levels, leading to energetic and oxidative damage in oocytes (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). By reducing Rab9, they could restore a better balance in mitochondria and redox state, thereby rescuing some age-related decline in oocyte quality (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). These findings suggest that tight control of Rab9 levels is important for maintaining healthy oocyte function. The authors conclude that Rab9 is “required to maintain the balance between mitochondrial function and meiosis” and that lowering Rab9 in aged oocytes might ameliorate age-related infertility (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). Although this research did not distinguish Rab9A vs Rab9B, the implication is that whichever isoform is present in oocytes (likely Rab9A primarily), an overabundance is detrimental. It highlights a novel link between Rab9-mediated trafficking (possibly of vesicles or organelles around the spindle) and the fidelity of cell division. For RAB9B, this raises the question: could certain tissues or conditions induce Rab9B as well, contributing to similar phenotypes? It’s known that RAB9B is expressed in the ovary (transcripts are detected in ovarian tissue), so its involvement in oocyte aging cannot be ruled out. This is a frontier area; further studies are needed to delineate isoform-specific roles in such contexts.

• Cancer and Other Diseases: While not as extensively studied as some Rabs, Rab9 dysregulation has been noted in cancer cell behavior. For instance, Rab9A was reported in 2020 to support liver cancer cell proliferation and survival, likely by aiding lysosome enzyme recycling and autophagy flux (pmc.ncbi.nlm.nih.gov). RAB9B itself has not been singled out in major cancer genomic studies, but given its functional overlap, it may also contribute to tumor cell homeostasis (especially in cells under metabolic stress that rely on efficient lysosomal recycling). Moreover, because Rab9 intersects with cholesterol transport (late endosomes are key organelles in cholesterol trafficking), there is interest in whether Rab9B influences metabolic diseases or neurodegenerative disorders where endolysosomal trafficking and lipid storage are disrupted. To date, no Mendelian diseases are directly attributed to mutations in RAB9B (and RAB9B has no entry in OMIM for a monogenic disorder). This could be due to redundancy with Rab9A or because null mutations might be embryonic lethal (given the vital role in enzyme trafficking). However, large genomic studies should be watched for any RAB9B variants associated with neurological or immunological conditions, as disruptions in membrane trafficking often manifest in those systems.

Conclusion and Expert Perspectives

RAB9B is recognized by cell biologists as an important regulator of intracellular traffic, particularly for its role in retrograde transport from endosomes to the Golgi. In the words of one authoritative review, “RAB9 proteins interact with the effector TIP47 to mediate receptor recognition and cargo selection” in endosome–TGN transport (pmc.ncbi.nlm.nih.gov). This highlights how Rab9 (A and B) form a critical link in the endosomal sorting machinery, ensuring key receptors like MPRs are recycled. More broadly, Rab9 and its effectors maintain the functionality of the late endosome–lysosome system, which is central to cellular homeostasis. Emerging research has expanded our understanding of RAB9B’s relevance: it now spans virology (as a host factor co-opted by viruses), neuroscience (oligodendrocyte development and myelin diseases), and reproductive aging (oocyte quality control). Such diverse roles underscore a common theme – RAB9B is a facilitator of targeted vesicle transport, and disturbances in this function can have cascading effects on cellular physiology. From an applied standpoint, experts are intrigued by the possibility of modulating Rab9 pathways for therapy. For example, Murray et al. noted in 2005 that Rab9 is “an important cellular target for inhibiting several unrelated viruses.” (pmc.ncbi.nlm.nih.gov) On the other hand, recent cell-specific studies suggest that inhibiting Rab9 might be beneficial in conditions like certain leukodystrophies or age-related oocyte decline (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). These ideas might seem counterintuitive (since Rab9 is usually needed for healthy cells), but it speaks to the complex role of membrane trafficking in different contexts – sometimes slowing a pathway can ameliorate a disease process (for instance, reducing Rab9 could relieve ER stress or excessive mitophagy in specialized cells).

In summary, RAB9B (Rab-9B) can be defined as a small GTP-binding protein that localizes to late endosomes and the Golgi, controlling the return flow of vesicular cargo to the TGN. It operates by cycling between active/inactive states and recruiting effectors like TIP47, p40, and NDE1 to execute vesicle budding and transport (www.genecards.org) (pubmed.ncbi.nlm.nih.gov). Its activity is vital for lysosomal enzyme recycling and has ripple effects on processes like viral assembly and cellular stress responses. While often working in concert with the more abundant Rab9A, RAB9B’s existence in the genome provides an additional layer of regulation (and potential backup) for this trafficking pathway. The current understanding, bolstered by 2023–2024 research, paints RAB9B as not only a housekeeping trafficking factor but also a participant in specialized cell adaptations (e.g. alternative autophagy and cell differentiation). Ongoing studies are likely to further clarify how RAB9B is regulated in various tissues and how it can be targeted or leveraged in disease settings. Given its central role in endosomal transport, RAB9B exemplifies the principle that intracellular logistics – the timely shuttling of proteins between compartments – is crucial for normal cell function and can be a double-edged sword in pathology. Researchers continue to monitor RAB9B and its pathway as a node where cellular pathways intersect, making it an interesting candidate for therapeutic intervention and a marker of cellular trafficking integrity.

References:

• Seki N. et al. (2000). “cDNA cloning of a new member of the Ras superfamily, RAB9-like, on human chromosome Xq22.” J. Hum. Genet. 45(3): 137–140. (UniProt Q9NP90, first identification)
• Carroll K.S. et al. (2001). “Role of Rab9 GTPase in facilitating receptor recruitment by TIP47.” Science 292(5520): 1373–1376. DOI:10.1126/science.1056791 (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov).
• Colicelli J. (2004). “Human RAS superfamily proteins and related GTPases.” Sci. STKE 2004(250): RE13. (Review; Rab9 summarized as above) (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov).
• Murray J.L. et al. (2005). “Rab9 GTPase is required for replication of HIV-1, filoviruses, and measles virus.” J. Virol. 79(18): 11742–11751. Published Sep 2005 (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov).
• Mackiewicz P. & Wyroba E. (2009). “Phylogeny and evolution of Rab7 and Rab9 proteins.” BMC Evol. Biol. 9:101. Published May 14, 2009 (pmc.ncbi.nlm.nih.gov).
• Nishida Y. et al. (2009). “Discovery of Atg5/Atg7-independent alternative macroautophagy.” Nature 461(7264): 654–658. DOI:10.1038/nature08455. (Rab9 in alternative autophagy)
• Nottingham R.M. et al. (2012). “RUTBC2 protein, a Rab9A effector and GTPase-activating protein for Rab36.” J. Biol. Chem. 287(27): 22740–22748. (Rab9A effector characterization)
• Lam C. et al. (2010). “Functional interplay between LIS1, NDE1 and NDEL1 in dynein-dependent organelle positioning.” J. Cell Sci. 123(Pt 2): 202–212. DOI:10.1242/jcs.059337. (Background on NDE1/NDEL1 in transport)
• Zhao X. et al. (2021). “Nde1 is a Rab9 effector for loading late endosomes onto cytoplasmic dynein.” Structure 29(12): 1321-1333.e4. DOI:10.1016/j.str.2021.08.009 (pubmed.ncbi.nlm.nih.gov).
• Haile Y. et al. (2024). “TMEM9 activates Rab9-dependent alternative autophagy through interaction with Beclin1.” Autophagy (Epub Jan 2024) DOI:10.1080/15548627.2023.2258288 (pubmed.ncbi.nlm.nih.gov).
• Fukushima N. et al. (2024). “Knockdown of Rab9 recovers defective morphological differentiation induced by ER stress or PMD-associated PLP1 mutant in oligodendroglial cells.” Pathophysiology 31(3): 420–435. Published Aug 26, 2024. DOI:10.3390/pathophysiology31030032 (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov).
• Gao M. et al. (2024). “Age-associated accumulation of RAB9 disrupts oocyte meiosis.” Aging Cell 24(4): e14449. Published Dec 15, 2024. DOI:10.1111/acel.14449 (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov).
• (Additional data and annotations sourced from NCBI Gene (ID:51209) [RefSeq 2010] (www.ncbi.nlm.nih.gov) and the Human Protein Atlas (www.proteinatlas.org) (www.proteinatlas.org).)

Citations

1. AnnotationURLCitation(end_index=415, start_index=311, title='RAB9B Gene - GeneCards | RAB9B Protein | RAB9B Antibody', type='url_citation', url='https://www.genecards.org/cgi-bin/carddisp.pl?gene=RAB9B#:~:text=,By%20similarity')
2. AnnotationURLCitation(end_index=673, start_index=569, title='RAB9B Gene - GeneCards | RAB9B Protein | RAB9B Antibody', type='url_citation', url='https://www.genecards.org/cgi-bin/carddisp.pl?gene=RAB9B#:~:text=,By%20similarity')
3. AnnotationURLCitation(end_index=945, start_index=801, title='RAB9B Gene - GeneCards | RAB9B Protein | RAB9B Antibody', type='url_citation', url='https://www.genecards.org/cgi-bin/carddisp.pl?gene=RAB9B#:~:text=Rabs%20cycle%20between%20an%20inactive,PubMed%3A34793709')
4. AnnotationURLCitation(end_index=1054, start_index=946, title='RAB9B Gene - GeneCards | RAB9B Protein | RAB9B Antibody', type='url_citation', url='https://www.genecards.org/cgi-bin/carddisp.pl?gene=RAB9B#:~:text=CatalyticActivity%3A')
5. AnnotationURLCitation(end_index=1346, start_index=1211, title='Knockdown of Rab9 Recovers Defective Morphological Differentiation Induced by Chemical ER Stress Inducer or PMD-Associated PLP1 Mutant Protein in FBD-102b Cells - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11417737/#:~:text=Rab9%20is%20divided%20into%20two,37%2C38%2C39%2C40')
6. AnnotationURLCitation(end_index=1740, start_index=1584, title='Knockdown of Rab9 Recovers Defective Morphological Differentiation Induced by Chemical ER Stress Inducer or PMD-Associated PLP1 Mutant Protein in FBD-102b Cells - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11417737/#:~:text=Rab9A%20is%20a%20general%20Rab9,the%20Human%20Protein%20Atlas%20website')
7. AnnotationURLCitation(end_index=1963, start_index=1830, title='cDNA cloning of a new member of the Ras superfamily, RAB9-like, on the human chromosome Xq22.1–q22.3 region | Journal of Human Genetics', type='url_citation', url='https://www.nature.com/articles/jhg200068#:~:text=cDNA%20cloning%20of%20a%20new,was%20isolated%20from%20a%20human')
8. AnnotationURLCitation(end_index=2303, start_index=2160, title='RAB9B RAB9B, member RAS oncogene family [Homo sapiens (human)] - Gene - NCBI', type='url_citation', url='https://www.ncbi.nlm.nih.gov/gene/51209#:~:text=Summary%20This%20gene%20encodes%20a,15%20other%20tissues%20See%20more')
9. AnnotationURLCitation(end_index=2625, start_index=2470, title='Phylogeny and evolution of Rab7 and Rab9 proteins - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2693434/#:~:text=match%20at%20L537%20The%20comparisons,more%20than%20two%20Rab7%20copies')
10. AnnotationURLCitation(end_index=2951, start_index=2796, title='Phylogeny and evolution of Rab7 and Rab9 proteins - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2693434/#:~:text=match%20at%20L537%20The%20comparisons,more%20than%20two%20Rab7%20copies')
11. AnnotationURLCitation(end_index=3241, start_index=3137, title='RAB9B Gene - GeneCards | RAB9B Protein | RAB9B Antibody', type='url_citation', url='https://www.genecards.org/cgi-bin/carddisp.pl?gene=RAB9B#:~:text=,By%20similarity')
12. AnnotationURLCitation(end_index=3524, start_index=3351, title='Human RAS Superfamily Proteins and Related GTPases - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2828947/#:~:text=RAS%20superfamily%20proteins%20share%20a,well%20conserved%20among%20superfamily%20members')
13. AnnotationURLCitation(end_index=3694, start_index=3525, title='Human RAS Superfamily Proteins and Related GTPases - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2828947/#:~:text=stabilizing%20interactions%20with%20G1%20box,more%20of%20its%20downstream%20effectors')
14. AnnotationURLCitation(end_index=4230, start_index=4070, title='Phylogeny and evolution of Rab7 and Rab9 proteins - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2693434/#:~:text=include%20highly%20supported%20sister%20clades,Moreover%2C%20two%20clustered')
15. AnnotationURLCitation(end_index=4878, start_index=4734, title='RAB9B gene information - The Human Protein Atlas', type='url_citation', url='https://www.proteinatlas.org/ENSG00000123570-RAB9B/summary/gene#:~:text=GO%3A0005525%20,secretory%20granule%20membrane')
16. AnnotationURLCitation(end_index=5022, start_index=4879, title='RAB9B gene information - The Human Protein Atlas', type='url_citation', url='https://www.proteinatlas.org/ENSG00000123570-RAB9B/summary/gene#:~:text=GO%3A0031410%20,identical%20protein%20binding')
17. AnnotationURLCitation(end_index=5914, start_index=5819, title='Human RAS Superfamily Proteins and Related GTPases - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2828947/#:~:text=%28Rab7,224')
18. AnnotationURLCitation(end_index=6293, start_index=6198, title='Human RAS Superfamily Proteins and Related GTPases - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2828947/#:~:text=%28Rab7,224')
19. AnnotationURLCitation(end_index=6515, start_index=6409, title='Human RAS Superfamily Proteins and Related GTPases - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2828947/#:~:text=%28Rab7,RAB27A%20works')
20. AnnotationURLCitation(end_index=6767, start_index=6661, title='Human RAS Superfamily Proteins and Related GTPases - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2828947/#:~:text=%28Rab7,RAB27A%20works')
21. AnnotationURLCitation(end_index=6985, start_index=6879, title='Human RAS Superfamily Proteins and Related GTPases - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2828947/#:~:text=%28Rab7,RAB27A%20works')
22. AnnotationURLCitation(end_index=7257, start_index=7162, title='Human RAS Superfamily Proteins and Related GTPases - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2828947/#:~:text=%28Rab7,224')
23. AnnotationURLCitation(end_index=7539, start_index=7438, title='Human RAS Superfamily Proteins and Related GTPases - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2828947/#:~:text=,Google%20Scholar')
24. AnnotationURLCitation(end_index=7889, start_index=7758, title='Rab9 GTPase Is Required for Replication of Human Immunodeficiency Virus Type 1, Filoviruses, and Measles Virus - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC1212642/#:~:text=TIP47,to%20silence%20Rab9%20expression%20before')
25. AnnotationURLCitation(end_index=8234, start_index=8078, title='Knockdown of Rab9 Recovers Defective Morphological Differentiation Induced by Chemical ER Stress Inducer or PMD-Associated PLP1 Mutant Protein in FBD-102b Cells - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11417737/#:~:text=Rab9A%20is%20a%20general%20Rab9,the%20Human%20Protein%20Atlas%20website')
26. AnnotationURLCitation(end_index=8551, start_index=8395, title='Knockdown of Rab9 Recovers Defective Morphological Differentiation Induced by Chemical ER Stress Inducer or PMD-Associated PLP1 Mutant Protein in FBD-102b Cells - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11417737/#:~:text=Rab9A%20is%20a%20general%20Rab9,the%20Human%20Protein%20Atlas%20website')
27. AnnotationURLCitation(end_index=8821, start_index=8684, title='Nde1 is a Rab9 effector for loading late endosomes to cytoplasmic dynein motor complex - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/34793709/#:~:text=Rab9%20is%20mainly%20located%20on,The%20functional%20roles')
28. AnnotationURLCitation(end_index=9206, start_index=9062, title='RAB9B gene information - The Human Protein Atlas', type='url_citation', url='https://www.proteinatlas.org/ENSG00000123570-RAB9B/summary/gene#:~:text=GO%3A0005525%20,secretory%20granule%20membrane')
29. AnnotationURLCitation(end_index=9667, start_index=9530, title='Nde1 is a Rab9 effector for loading late endosomes to cytoplasmic dynein motor complex - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/34793709/#:~:text=Rab9%20is%20mainly%20located%20on,The%20functional%20roles')
30. AnnotationURLCitation(end_index=10080, start_index=9937, title='Nde1 is a Rab9 effector for loading late endosomes to cytoplasmic dynein motor complex - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/34793709/#:~:text=triphosphate%20%28GTP%29,retrograde%20transport%20to%20the%20TGN')
31. AnnotationURLCitation(end_index=10457, start_index=10314, title='Nde1 is a Rab9 effector for loading late endosomes to cytoplasmic dynein motor complex - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/34793709/#:~:text=triphosphate%20%28GTP%29,retrograde%20transport%20to%20the%20TGN')
32. AnnotationURLCitation(end_index=10753, start_index=10610, title='Nde1 is a Rab9 effector for loading late endosomes to cytoplasmic dynein motor complex - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/34793709/#:~:text=triphosphate%20%28GTP%29,retrograde%20transport%20to%20the%20TGN')
33. AnnotationURLCitation(end_index=11023, start_index=10899, title='Nde1 is a Rab9 effector for loading late endosomes to cytoplasmic dynein motor complex - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/34793709/#:~:text=Rab9A,retrograde%20transport%20to%20the%20TGN')
34. AnnotationURLCitation(end_index=11427, start_index=11290, title='Nde1 is a Rab9 effector for loading late endosomes to cytoplasmic dynein motor complex - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/34793709/#:~:text=Rab9%20is%20mainly%20located%20on,The%20functional%20roles')
35. AnnotationURLCitation(end_index=11571, start_index=11428, title='Nde1 is a Rab9 effector for loading late endosomes to cytoplasmic dynein motor complex - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/34793709/#:~:text=triphosphate%20%28GTP%29,retrograde%20transport%20to%20the%20TGN')
36. AnnotationURLCitation(end_index=12233, start_index=12089, title='RAB9B gene information - The Human Protein Atlas', type='url_citation', url='https://www.proteinatlas.org/ENSG00000123570-RAB9B/summary/gene#:~:text=GO%3A0005525%20,secretory%20granule%20membrane')
37. AnnotationURLCitation(end_index=12377, start_index=12234, title='RAB9B gene information - The Human Protein Atlas', type='url_citation', url='https://www.proteinatlas.org/ENSG00000123570-RAB9B/summary/gene#:~:text=GO%3A0031410%20,identical%20protein%20binding')
38. AnnotationURLCitation(end_index=12649, start_index=12471, title='Knockdown of Rab9 Recovers Defective Morphological Differentiation Induced by Chemical ER Stress Inducer or PMD-Associated PLP1 Mutant Protein in FBD-102b Cells - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11417737/#:~:text=trafficking%20across%20many%20aspects%20of,expression%20levels%20of%20oligodendroglial%20cell')
39. AnnotationURLCitation(end_index=12804, start_index=12650, title='Rab9 GTPase Is Required for Replication of Human Immunodeficiency Virus Type 1, Filoviruses, and Measles Virus - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC1212642/#:~:text=membrane%20transport%29%20%2852%20%29,out%20of%20the%20late%20endosome')
40. AnnotationURLCitation(end_index=13304, start_index=13162, title='Rab9 GTPase Is Required for Replication of Human Immunodeficiency Virus Type 1, Filoviruses, and Measles Virus - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC1212642/#:~:text=viral%20infection,replication%20was%20dependent%20on%20the')
41. AnnotationURLCitation(end_index=13459, start_index=13305, title='Rab9 GTPase Is Required for Replication of Human Immunodeficiency Virus Type 1, Filoviruses, and Measles Virus - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC1212642/#:~:text=membrane%20transport%29%20%2852%20%29,out%20of%20the%20late%20endosome')
42. AnnotationURLCitation(end_index=13744, start_index=13602, title='Rab9 GTPase Is Required for Replication of Human Immunodeficiency Virus Type 1, Filoviruses, and Measles Virus - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC1212642/#:~:text=viral%20infection,replication%20was%20dependent%20on%20the')
43. AnnotationURLCitation(end_index=13899, start_index=13745, title='Rab9 GTPase Is Required for Replication of Human Immunodeficiency Virus Type 1, Filoviruses, and Measles Virus - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC1212642/#:~:text=membrane%20transport%29%20%2852%20%29,out%20of%20the%20late%20endosome')
44. AnnotationURLCitation(end_index=14253, start_index=14122, title='Rab9 GTPase Is Required for Replication of Human Immunodeficiency Virus Type 1, Filoviruses, and Measles Virus - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC1212642/#:~:text=TIP47,to%20silence%20Rab9%20expression%20before')
45. AnnotationURLCitation(end_index=14408, start_index=14254, title='Rab9 GTPase Is Required for Replication of Human Immunodeficiency Virus Type 1, Filoviruses, and Measles Virus - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC1212642/#:~:text=membrane%20transport%29%20%2852%20%29,out%20of%20the%20late%20endosome')
46. AnnotationURLCitation(end_index=14789, start_index=14694, title='Human RAS Superfamily Proteins and Related GTPases - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2828947/#:~:text=%28Rab7,224')
47. AnnotationURLCitation(end_index=15152, start_index=14991, title='Rab9 GTPase Is Required for Replication of Human Immunodeficiency Virus Type 1, Filoviruses, and Measles Virus - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC1212642/#:~:text=surviving%20the%20cytopathic%20effects%20of,is%20thought%20to%20depend%20upon')
48. AnnotationURLCitation(end_index=15439, start_index=15278, title='Rab9 GTPase Is Required for Replication of Human Immunodeficiency Virus Type 1, Filoviruses, and Measles Virus - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC1212642/#:~:text=surviving%20the%20cytopathic%20effects%20of,is%20thought%20to%20depend%20upon')
49. AnnotationURLCitation(end_index=15756, start_index=15595, title='Rab9 GTPase Is Required for Replication of Human Immunodeficiency Virus Type 1, Filoviruses, and Measles Virus - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC1212642/#:~:text=surviving%20the%20cytopathic%20effects%20of,is%20thought%20to%20depend%20upon')
50. AnnotationURLCitation(end_index=16218, start_index=16076, title='Rab9 GTPase Is Required for Replication of Human Immunodeficiency Virus Type 1, Filoviruses, and Measles Virus - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC1212642/#:~:text=viral%20infection,replication%20was%20dependent%20on%20the')
51. AnnotationURLCitation(end_index=16725, start_index=16564, title='Nde1 is a Rab9 effector for loading late endosomes to cytoplasmic dynein motor complex - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/34793709/#:~:text=retrograde%20transport%20remains%20unclear,retrograde%20transport%20to%20the%20TGN')
52. AnnotationURLCitation(end_index=16887, start_index=16726, title='Nde1 is a Rab9 effector for loading late endosomes to cytoplasmic dynein motor complex - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/34793709/#:~:text=failed%20to%20associate%20with%20dynein%2C,retrograde%20transport%20to%20the%20TGN')
53. AnnotationURLCitation(end_index=17520, start_index=17353, title='Knockdown of Rab9 Recovers Defective Morphological Differentiation Induced by Chemical ER Stress Inducer or PMD-Associated PLP1 Mutant Protein in FBD-102b Cells - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11417737/#:~:text=However%2C%20Rab9A%20and%20Rab9B%20exhibit,the%20Human%20Protein%20Atlas%20website')
54. AnnotationURLCitation(end_index=18602, start_index=18441, title='Rab9 GTPase Is Required for Replication of Human Immunodeficiency Virus Type 1, Filoviruses, and Measles Virus - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC1212642/#:~:text=surviving%20the%20cytopathic%20effects%20of,is%20thought%20to%20depend%20upon')
55. AnnotationURLCitation(end_index=18960, start_index=18796, title='Knockdown of Rab9 Recovers Defective Morphological Differentiation Induced by Chemical ER Stress Inducer or PMD-Associated PLP1 Mutant Protein in FBD-102b Cells - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11417737/#:~:text=Knockdown%20of%20Rab9%20Recovers%20Defective,a%20similar%20function%20as%20that')
56. AnnotationURLCitation(end_index=19200, start_index=19078, title='Rab9A is required for delivery of cargo from recycling endosomes to melanosomes - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC4690521/#:~:text=,role%20of%20Rab9A%20remains%20unknown')
57. AnnotationURLCitation(end_index=19749, start_index=19589, title='TMEM9 activates Rab9-dependent alternative autophagy through interaction with Beclin1 - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/39078420/#:~:text=autophagy%20through%20its%20interaction%20with,the%20Beclin1%20complex%20at%20the')
58. AnnotationURLCitation(end_index=20039, start_index=19879, title='TMEM9 activates Rab9-dependent alternative autophagy through interaction with Beclin1 - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/39078420/#:~:text=autophagy%20through%20its%20interaction%20with,the%20Beclin1%20complex%20at%20the')
59. AnnotationURLCitation(end_index=20422, start_index=20262, title='TMEM9 activates Rab9-dependent alternative autophagy through interaction with Beclin1 - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/39078420/#:~:text=autophagy%20through%20its%20interaction%20with,the%20Beclin1%20complex%20at%20the')
60. AnnotationURLCitation(end_index=20717, start_index=20598, title='Autophagy takes an alternative route | Nature Reviews Molecular Cell Biology', type='url_citation', url='https://www.nature.com/articles/nrm2790#:~:text=Biology%20www,and%20deliver%20them%20to%20lysosomes')
61. AnnotationURLCitation(end_index=21047, start_index=20887, title='TMEM9 activates Rab9-dependent alternative autophagy through interaction with Beclin1 - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/39078420/#:~:text=autophagy%20through%20its%20interaction%20with,the%20Beclin1%20complex%20at%20the')
62. AnnotationURLCitation(end_index=21394, start_index=21244, title='Autophagy takes an alternative route | Nature Reviews Molecular Cell Biology', type='url_citation', url='https://www.nature.com/articles/nrm2790#:~:text=Autophagy%20takes%20an%20alternative%20route,and%20deliver%20them%20to%20lysosomes')
63. AnnotationURLCitation(end_index=21773, start_index=21681, title='RAB9B RAB9B, member RAS oncogene family [Homo sapiens (human)] - Gene - NCBI', type='url_citation', url='https://www.ncbi.nlm.nih.gov/gene/51209#:~:text=Location%3A%20Xq22')
64. AnnotationURLCitation(end_index=22152, start_index=22013, title='Knockdown of Rab9 Recovers Defective Morphological Differentiation Induced by Chemical ER Stress Inducer or PMD-Associated PLP1 Mutant Protein in FBD-102b Cells - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11417737/#:~:text=Rab9B%20genes%20,to%20clarify%20the%20association%20of')
65. AnnotationURLCitation(end_index=22508, start_index=22419, title='Knockdown of Rab9 Recovers Defective Morphological Differentiation Induced by Chemical ER Stress Inducer or PMD-Associated PLP1 Mutant Protein in FBD-102b Cells - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11417737/#:~:text=,DOI')
66. AnnotationURLCitation(end_index=22778, start_index=22622, title='Knockdown of Rab9 Recovers Defective Morphological Differentiation Induced by Chemical ER Stress Inducer or PMD-Associated PLP1 Mutant Protein in FBD-102b Cells - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11417737/#:~:text=match%20at%20L656%20Rab9B%20genes,to%20clarify%20the%20association%20of')
67. AnnotationURLCitation(end_index=23143, start_index=22987, title='Knockdown of Rab9 Recovers Defective Morphological Differentiation Induced by Chemical ER Stress Inducer or PMD-Associated PLP1 Mutant Protein in FBD-102b Cells - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11417737/#:~:text=match%20at%20L656%20Rab9B%20genes,to%20clarify%20the%20association%20of')
68. AnnotationURLCitation(end_index=23776, start_index=23609, title='Knockdown of Rab9 Recovers Defective Morphological Differentiation Induced by Chemical ER Stress Inducer or PMD-Associated PLP1 Mutant Protein in FBD-102b Cells - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11417737/#:~:text=However%2C%20Rab9A%20and%20Rab9B%20exhibit,the%20Human%20Protein%20Atlas%20website')
69. AnnotationURLCitation(end_index=24086, start_index=23919, title='Knockdown of Rab9 Recovers Defective Morphological Differentiation Induced by Chemical ER Stress Inducer or PMD-Associated PLP1 Mutant Protein in FBD-102b Cells - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11417737/#:~:text=However%2C%20Rab9A%20and%20Rab9B%20exhibit,the%20Human%20Protein%20Atlas%20website')
70. AnnotationURLCitation(end_index=24511, start_index=24418, title='RAB9B RAB9B, member RAS oncogene family [Homo sapiens (human)] - Gene - NCBI', type='url_citation', url='https://www.ncbi.nlm.nih.gov/gene/51209#:~:text=Exon%20count%3A%209')
71. AnnotationURLCitation(end_index=24792, start_index=24644, title='RAB9B gene information - The Human Protein Atlas', type='url_citation', url='https://www.proteinatlas.org/ENSG00000123570-RAB9B/summary/gene#:~:text=Mapped%20to%20neXtProt%20neXtProt%20,GTP%20binding')
72. AnnotationURLCitation(end_index=24992, start_index=24862, title='RAB9B gene information - The Human Protein Atlas', type='url_citation', url='https://www.proteinatlas.org/ENSG00000123570-RAB9B/summary/gene#:~:text=GO%3A0042147%20,7%20kDa%20No%200')
73. AnnotationURLCitation(end_index=25658, start_index=25490, title='Age‐associated accumulation of RAB9 disrupts oocyte meiosis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11984694/#:~:text=The%20critical%20role%20of%20some,disrupts%20spindle%20formation%20and%20chromosome')
74. AnnotationURLCitation(end_index=25851, start_index=25659, title='Age‐associated accumulation of RAB9 disrupts oocyte meiosis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11984694/#:~:text=located%20at%20the%20meiotic%20spindle,Rab9%E2%80%90OE%20activates%20the%20PINK1%E2%80%90PARKIN%20mitophagy')
75. AnnotationURLCitation(end_index=26145, start_index=26002, title='RAB9B RAB9B, member RAS oncogene family [Homo sapiens (human)] - Gene - NCBI', type='url_citation', url='https://www.ncbi.nlm.nih.gov/gene/51209#:~:text=Summary%20This%20gene%20encodes%20a,15%20other%20tissues%20See%20more')
76. AnnotationURLCitation(end_index=26388, start_index=26233, title='Phylogeny and evolution of Rab7 and Rab9 proteins - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2693434/#:~:text=match%20at%20L537%20The%20comparisons,more%20than%20two%20Rab7%20copies')
77. AnnotationURLCitation(end_index=27446, start_index=27277, title='Rab9 GTPase Is Required for Replication of Human Immunodeficiency Virus Type 1, Filoviruses, and Measles Virus - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC1212642/#:~:text=Marburg%2C%20and%20measles%20viruses%20was,membrane%20vesicular%20transport%20pathway')
78. AnnotationURLCitation(end_index=27622, start_index=27447, title='Rab9 GTPase Is Required for Replication of Human Immunodeficiency Virus Type 1, Filoviruses, and Measles Virus - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC1212642/#:~:text=replication%20of%20the%20enveloped%20Ebola,for%20inhibiting%20several%20unrelated%20viruses')
79. AnnotationURLCitation(end_index=27850, start_index=27708, title='Rab9 GTPase Is Required for Replication of Human Immunodeficiency Virus Type 1, Filoviruses, and Measles Virus - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC1212642/#:~:text=viral%20infection,replication%20was%20dependent%20on%20the')
80. AnnotationURLCitation(end_index=28020, start_index=27851, title='Rab9 GTPase Is Required for Replication of Human Immunodeficiency Virus Type 1, Filoviruses, and Measles Virus - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC1212642/#:~:text=Marburg%2C%20and%20measles%20viruses%20was,membrane%20vesicular%20transport%20pathway')
81. AnnotationURLCitation(end_index=28324, start_index=28193, title='Rab9 GTPase Is Required for Replication of Human Immunodeficiency Virus Type 1, Filoviruses, and Measles Virus - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC1212642/#:~:text=TIP47,to%20silence%20Rab9%20expression%20before')
82. AnnotationURLCitation(end_index=28619, start_index=28477, title='Rab9 GTPase Is Required for Replication of Human Immunodeficiency Virus Type 1, Filoviruses, and Measles Virus - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC1212642/#:~:text=viral%20infection,replication%20was%20dependent%20on%20the')
83. AnnotationURLCitation(end_index=28943, start_index=28778, title='Rab9 GTPase Is Required for Replication of Human Immunodeficiency Virus Type 1, Filoviruses, and Measles Virus - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC1212642/#:~:text=donor%20vesicles%20to%20their%20respective,budding%20at%20the%20plasma%20membrane')
84. AnnotationURLCitation(end_index=29104, start_index=28944, title='Rab9 GTPase Is Required for Replication of Human Immunodeficiency Virus Type 1, Filoviruses, and Measles Virus - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC1212642/#:~:text=disruption%20allowed%20the%20survival%20of,for%20HIV%20assembly%20and%20that')
85. AnnotationURLCitation(end_index=29409, start_index=29286, title='Rab9 GTPase Is Required for Replication of Human Immunodeficiency Virus Type 1, Filoviruses, and Measles Virus - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC1212642/#:~:text=match%20at%20L115%20reports%20provide,2')
86. AnnotationURLCitation(end_index=29534, start_index=29410, title='Rab9 GTPase Is Required for Replication of Human Immunodeficiency Virus Type 1, Filoviruses, and Measles Virus - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC1212642/#:~:text=reports%20provide%20evidence%20for%20a,2')
87. AnnotationURLCitation(end_index=29861, start_index=29692, title='Rab9 GTPase Is Required for Replication of Human Immunodeficiency Virus Type 1, Filoviruses, and Measles Virus - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC1212642/#:~:text=Marburg%2C%20and%20measles%20viruses%20was,membrane%20vesicular%20transport%20pathway')
88. AnnotationURLCitation(end_index=30234, start_index=30059, title='Rab9 GTPase Is Required for Replication of Human Immunodeficiency Virus Type 1, Filoviruses, and Measles Virus - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC1212642/#:~:text=replication%20of%20the%20enveloped%20Ebola,for%20inhibiting%20several%20unrelated%20viruses')
89. AnnotationURLCitation(end_index=30404, start_index=30235, title='Rab9 GTPase Is Required for Replication of Human Immunodeficiency Virus Type 1, Filoviruses, and Measles Virus - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC1212642/#:~:text=match%20at%20L129%20replication%20of,for%20inhibiting%20several%20unrelated%20viruses')
90. AnnotationURLCitation(end_index=30694, start_index=30564, title='CA2557426A1 - Rab9a, rab11a, and modulators thereof related to infectious disease - Google Patents', type='url_citation', url='https://patents.google.com/patent/CA2557426A1/en#:~:text=CA2557426A1%20,as%20a%20decrease%20in%20infection')
91. AnnotationURLCitation(end_index=31450, start_index=31302, title='Knockdown of Rab9 Recovers Defective Morphological Differentiation Induced by Chemical ER Stress Inducer or PMD-Associated PLP1 Mutant Protein in FBD-102b Cells - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11417737/#:~:text=match%20at%20L651%20Rab9A%20is,note%20that%20a%20patient%20with')
92. AnnotationURLCitation(end_index=31756, start_index=31630, title='Knockdown of Rab9 Recovers Defective Morphological Differentiation Induced by Chemical ER Stress Inducer or PMD-Associated PLP1 Mutant Protein in FBD-102b Cells - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11417737/#:~:text=first%20time%2C%20we%20report%20that,HLD1')
93. AnnotationURLCitation(end_index=32085, start_index=31959, title='Knockdown of Rab9 Recovers Defective Morphological Differentiation Induced by Chemical ER Stress Inducer or PMD-Associated PLP1 Mutant Protein in FBD-102b Cells - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11417737/#:~:text=first%20time%2C%20we%20report%20that,HLD1')
94. AnnotationURLCitation(end_index=32240, start_index=32086, title='Knockdown of Rab9 Recovers Defective Morphological Differentiation Induced by Chemical ER Stress Inducer or PMD-Associated PLP1 Mutant Protein in FBD-102b Cells - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11417737/#:~:text=morphological%20differentiation,ER%20stress%20marker%20proteins%20and')
95. AnnotationURLCitation(end_index=32600, start_index=32430, title='Knockdown of Rab9 Recovers Defective Morphological Differentiation Induced by Chemical ER Stress Inducer or PMD-Associated PLP1 Mutant Protein in FBD-102b Cells - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11417737/#:~:text=were%20accompanied%20by%20increased%20expression,stress%20inducer%2C%20as%20well%20as')
96. AnnotationURLCitation(end_index=32945, start_index=32775, title='Knockdown of Rab9 Recovers Defective Morphological Differentiation Induced by Chemical ER Stress Inducer or PMD-Associated PLP1 Mutant Protein in FBD-102b Cells - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11417737/#:~:text=were%20accompanied%20by%20increased%20expression,stress%20inducer%2C%20as%20well%20as')
97. AnnotationURLCitation(end_index=33534, start_index=33363, title='Knockdown of Rab9 Recovers Defective Morphological Differentiation Induced by Chemical ER Stress Inducer or PMD-Associated PLP1 Mutant Protein in FBD-102b Cells - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11417737/#:~:text=the%20major%20causes%20of%20oligodendroglial,the%20molecular%20and%20cellular%20levels')
98. AnnotationURLCitation(end_index=33753, start_index=33597, title='Knockdown of Rab9 Recovers Defective Morphological Differentiation Induced by Chemical ER Stress Inducer or PMD-Associated PLP1 Mutant Protein in FBD-102b Cells - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11417737/#:~:text=match%20at%20L656%20Rab9B%20genes,to%20clarify%20the%20association%20of')
99. AnnotationURLCitation(end_index=34629, start_index=34449, title='Age‐associated accumulation of RAB9 disrupts oocyte meiosis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11984694/#:~:text=Here%2C%20we%20report%20that%20the,Mechanically%2C%20Rab9%E2%80%90OE%20increases%20ROS%20levels')
100. AnnotationURLCitation(end_index=34822, start_index=34630, title='Age‐associated accumulation of RAB9 disrupts oocyte meiosis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11984694/#:~:text=located%20at%20the%20meiotic%20spindle,Rab9%E2%80%90OE%20activates%20the%20PINK1%E2%80%90PARKIN%20mitophagy')
101. AnnotationURLCitation(end_index=35244, start_index=35052, title='Age‐associated accumulation of RAB9 disrupts oocyte meiosis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11984694/#:~:text=located%20at%20the%20meiotic%20spindle,Rab9%E2%80%90OE%20activates%20the%20PINK1%E2%80%90PARKIN%20mitophagy')
102. AnnotationURLCitation(end_index=35407, start_index=35245, title='Age‐associated accumulation of RAB9 disrupts oocyte meiosis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11984694/#:~:text=increased%20in%20old%20oocytes,of%20old%20oocyte%20maturation%2C%20ameliorate')
103. AnnotationURLCitation(end_index=35776, start_index=35608, title='Age‐associated accumulation of RAB9 disrupts oocyte meiosis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11984694/#:~:text=reduces%20the%20cortical%20actin%20levels,and%20that%20reducing%20RAB9%20expression')
104. AnnotationURLCitation(end_index=35965, start_index=35777, title='Age‐associated accumulation of RAB9 disrupts oocyte meiosis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11984694/#:~:text=oocytes%20could%20partially%20improve%20the,age%E2%80%90related%20deterioration%20of%20oocyte%20quality')
105. AnnotationURLCitation(end_index=36307, start_index=36145, title='Age‐associated accumulation of RAB9 disrupts oocyte meiosis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11984694/#:~:text=increased%20in%20old%20oocytes,of%20old%20oocyte%20maturation%2C%20ameliorate')
106. AnnotationURLCitation(end_index=36476, start_index=36308, title='Age‐associated accumulation of RAB9 disrupts oocyte meiosis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11984694/#:~:text=reduces%20the%20cortical%20actin%20levels,and%20that%20reducing%20RAB9%20expression')
107. AnnotationURLCitation(end_index=36775, start_index=36625, title='Age‐associated accumulation of RAB9 disrupts oocyte meiosis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11984694/#:~:text=ratio,age%E2%80%90related%20deterioration%20of%20oocyte%20quality')
108. AnnotationURLCitation(end_index=36964, start_index=36776, title='Age‐associated accumulation of RAB9 disrupts oocyte meiosis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11984694/#:~:text=oocytes%20could%20partially%20improve%20the,age%E2%80%90related%20deterioration%20of%20oocyte%20quality')
109. AnnotationURLCitation(end_index=37429, start_index=37279, title='Age‐associated accumulation of RAB9 disrupts oocyte meiosis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11984694/#:~:text=ratio,age%E2%80%90related%20deterioration%20of%20oocyte%20quality')
110. AnnotationURLCitation(end_index=37626, start_index=37430, title='Age‐associated accumulation of RAB9 disrupts oocyte meiosis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11984694/#:~:text=partially%20rescue%20ATP%20levels%2C%20mtDNA%2FnDNA,age%E2%80%90related%20deterioration%20of%20oocyte%20quality')
111. AnnotationURLCitation(end_index=38766, start_index=38657, title='RAB9A Plays an Oncogenic Role in Human Liver Cancer Cells - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC7210512/#:~:text=PMC%20pmc,Article%20notes')
112. AnnotationURLCitation(end_index=40264, start_index=40169, title='Human RAS Superfamily Proteins and Related GTPases - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2828947/#:~:text=%28Rab7,224')
113. AnnotationURLCitation(end_index=41413, start_index=41244, title='Rab9 GTPase Is Required for Replication of Human Immunodeficiency Virus Type 1, Filoviruses, and Measles Virus - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC1212642/#:~:text=match%20at%20L129%20replication%20of,for%20inhibiting%20several%20unrelated%20viruses')
114. AnnotationURLCitation(end_index=41758, start_index=41587, title='Knockdown of Rab9 Recovers Defective Morphological Differentiation Induced by Chemical ER Stress Inducer or PMD-Associated PLP1 Mutant Protein in FBD-102b Cells - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11417737/#:~:text=the%20major%20causes%20of%20oligodendroglial,the%20molecular%20and%20cellular%20levels')
115. AnnotationURLCitation(end_index=41947, start_index=41759, title='Age‐associated accumulation of RAB9 disrupts oocyte meiosis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11984694/#:~:text=oocytes%20could%20partially%20improve%20the,age%E2%80%90related%20deterioration%20of%20oocyte%20quality')
116. AnnotationURLCitation(end_index=42721, start_index=42617, title='RAB9B Gene - GeneCards | RAB9B Protein | RAB9B Antibody', type='url_citation', url='https://www.genecards.org/cgi-bin/carddisp.pl?gene=RAB9B#:~:text=,By%20similarity')
117. AnnotationURLCitation(end_index=42865, start_index=42722, title='Nde1 is a Rab9 effector for loading late endosomes to cytoplasmic dynein motor complex - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/34793709/#:~:text=triphosphate%20%28GTP%29,retrograde%20transport%20to%20the%20TGN')
118. AnnotationURLCitation(end_index=44523, start_index=44422, title='Human RAS Superfamily Proteins and Related GTPases - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2828947/#:~:text=,Google%20Scholar')
119. AnnotationURLCitation(end_index=44619, start_index=44524, title='Human RAS Superfamily Proteins and Related GTPases - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2828947/#:~:text=%28Rab7,224')
120. AnnotationURLCitation(end_index=44863, start_index=44768, title='Human RAS Superfamily Proteins and Related GTPases - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2828947/#:~:text=%28Rab7,224')
121. AnnotationURLCitation(end_index=44970, start_index=44864, title='Human RAS Superfamily Proteins and Related GTPases - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2828947/#:~:text=%28Rab7,RAB27A%20works')
122. AnnotationURLCitation(end_index=45285, start_index=45145, title='Rab9 GTPase Is Required for Replication of Human Immunodeficiency Virus Type 1, Filoviruses, and Measles Virus - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC1212642/#:~:text=Rab%20proteins%20and%20their%20effectors,Golgi%20network')
123. AnnotationURLCitation(end_index=45428, start_index=45286, title='Rab9 GTPase Is Required for Replication of Human Immunodeficiency Virus Type 1, Filoviruses, and Measles Virus - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC1212642/#:~:text=viral%20infection,replication%20was%20dependent%20on%20the')
124. AnnotationURLCitation(end_index=45598, start_index=45429, title='Rab9 GTPase Is Required for Replication of Human Immunodeficiency Virus Type 1, Filoviruses, and Measles Virus - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC1212642/#:~:text=Marburg%2C%20and%20measles%20viruses%20was,membrane%20vesicular%20transport%20pathway')
125. AnnotationURLCitation(end_index=45898, start_index=45743, title='Phylogeny and evolution of Rab7 and Rab9 proteins - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2693434/#:~:text=match%20at%20L537%20The%20comparisons,more%20than%20two%20Rab7%20copies')
126. AnnotationURLCitation(end_index=46822, start_index=46679, title='Nde1 is a Rab9 effector for loading late endosomes to cytoplasmic dynein motor complex - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/34793709/#:~:text=triphosphate%20%28GTP%29,retrograde%20transport%20to%20the%20TGN')
127. AnnotationURLCitation(end_index=47170, start_index=47010, title='TMEM9 activates Rab9-dependent alternative autophagy through interaction with Beclin1 - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/39078420/#:~:text=autophagy%20through%20its%20interaction%20with,the%20Beclin1%20complex%20at%20the')
128. AnnotationURLCitation(end_index=47608, start_index=47452, title='Knockdown of Rab9 Recovers Defective Morphological Differentiation Induced by Chemical ER Stress Inducer or PMD-Associated PLP1 Mutant Protein in FBD-102b Cells - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11417737/#:~:text=Rab9A%20is%20a%20general%20Rab9,the%20Human%20Protein%20Atlas%20website')
129. AnnotationURLCitation(end_index=47776, start_index=47609, title='Knockdown of Rab9 Recovers Defective Morphological Differentiation Induced by Chemical ER Stress Inducer or PMD-Associated PLP1 Mutant Protein in FBD-102b Cells - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11417737/#:~:text=However%2C%20Rab9A%20and%20Rab9B%20exhibit,the%20Human%20Protein%20Atlas%20website')
130. AnnotationURLCitation(end_index=48117, start_index=47949, title='Age‐associated accumulation of RAB9 disrupts oocyte meiosis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11984694/#:~:text=The%20critical%20role%20of%20some,disrupts%20spindle%20formation%20and%20chromosome')
131. AnnotationURLCitation(end_index=48286, start_index=48118, title='Age‐associated accumulation of RAB9 disrupts oocyte meiosis - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11984694/#:~:text=reduces%20the%20cortical%20actin%20levels,and%20that%20reducing%20RAB9%20expression')
132. AnnotationURLCitation(end_index=48522, start_index=48374, title='RAB9B RAB9B, member RAS oncogene family [Homo sapiens (human)] - Gene - NCBI', type='url_citation', url='https://www.ncbi.nlm.nih.gov/gene/51209#:~:text=Summary%20This%20gene%20encodes%20a,provided%20by%20RefSeq%2C%20Jan%202010')
133. AnnotationURLCitation(end_index=48696, start_index=48552, title='RAB9B gene information - The Human Protein Atlas', type='url_citation', url='https://www.proteinatlas.org/ENSG00000123570-RAB9B/summary/gene#:~:text=GO%3A0005525%20,secretory%20granule%20membrane')
134. AnnotationURLCitation(end_index=48840, start_index=48697, title='RAB9B gene information - The Human Protein Atlas', type='url_citation', url='https://www.proteinatlas.org/ENSG00000123570-RAB9B/summary/gene#:~:text=GO%3A0031410%20,identical%20protein%20binding')